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I have worked with a broad array of clinical neuropsychological issues, both at Rogaland 
A-Centre in Stavanger and at the Department of Physical Medicine and Rehabilitation at 
Stavanger University Hospital. This work has revolved mainly around diagnosing patients 
with different neurocognitive impairments, either as sequelae to chronic substance use 
disorder (SUD) or due to head trauma, solvent exposure, or other risk factors. On several 
occasions, I reconnected with patients I had previously diagnosed, who had managed to control 
their SUD and achieve sobriety. I could not help noticing that some of these patients had made 
significant improvements in neuropsychological functioning, most likely due to a change in 
drug use and its associated lifestyle. Hence, I started to question the long-term validity of a 
single neuropsychological assessment, its corresponding diagnosis, and its ramifications. 
I had the privilege of getting to know my current Research Director Dr. Sverre Nesvåg 
when he was Director at Rogaland A-Center. After Dr. Nesvåg had established the Regional 
Competence Center for Alcohol and Drug Research (KORFOR) in Stavanger, I had the 
opportunity to embark on the current PhD project. Dr. Nesvåg and I agreed that we wanted to 
investigate neurocognitive recovery processes, rather than the commonly investigated 
neurotoxic effects of different drugs. While his support, enthusiasm and knowledge extend 
beyond the project, they have been very valuable for both the initiation and completion of it. 
Research within this field involves several methodological challenges, which we will 
detail later in this chapter. One of the main challenges was to motivate the involved clinical 
institutions to give us access to patients, and on our behalf, to do what was possible to reduce 
dropout from the research project. We also wanted to retain patients in the project while they 
were in treatment, out of treatment, in jail, out of jail, and for an extended period. This work 
was possible because of the effort and talent of our research assistant Thomas Solgård 
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Svendsen, who was the first to be recruited in this role. Later, Anne-Lill Mjølhus Njaa was 
also employed in an equivalent role. Along with Janne Årstad, they played a crucial role in the 
running of the project and managed to keep attrition low. 
The project was built completely from scratch, and few of my colleagues had training and 
work experience within the field of neuropsychology. I, therefore, knew that it was vital to 
connect with skilled professionals within this field. The initial process led me to Dr. Espen 
Walderhaug at Oslo University Hospital who became my main supervisor. He has supported 
and inspired me during these many years. I was also fortunate to have Professor Astri J. 
Lundervold at the University of Bergen as my cosupervisor. They have both been vital for the 
completion of my thesis. Furthermore, Professor James R. McKay, who heads the Centre on 
the Continuum of Care in the Addictions at the University of Pennsylvania, gave me the 
opportunity to take part in an international collaboration, and to complete a four-week research 
stay with his group in the USA. His contribution has been very inspiring, and I sincerely hope 
this will be the beginning of a lasting collaboration. 
Research interest, like addiction, runs in families. Some of my co-authors are also family, 
and without my nephew, PhD candidate and psychologist Aleksander H. Erga, and my 
daughter, Katrin P. Hagen, who is soon to be a specialist in clinical neuropsychology, this 
would have been an even more challenging road to travel. 
I am also deeply grateful for the support and inspiration from all my colleagues in the 
Centre for Alcohol and Drug Research, Stavanger University Hospital. I would like to thank 
Espen A. Enoksen for handling all the organizational and financial issues around setting up 
the project. My thanks go to Randi Mobæk, Director of the Department of Young Adults, 
where I held a parallel advisory role throughout the entire PhD period; her genuine interest in 
new clinical knowledge and her continuous support have been vital for the completion of the 
thesis. I am very grateful to all the patients for their participation in the project; they have 
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contributed to research in a central clinical field, and it is hoped that this will help bring 
treatment for SUD a small step forward. 
Finally, I express my gratitude to my wife Bjørg, for her love, support, and continued trust 





Neurocognitive impairment affects quality of life, occupational functioning, and the ability 
to benefit from therapy. Neurocognitive assessment is thus of importance, but it is expensive 
and not widely accessible. Therefore, in a hectic clinical setting, a procedure that includes 
measures that target core cognitive deficits would be beneficial. Paper I investigate the utility 
of psychometric tests, and a questionnaire-based inventory to assess “hot” and “cold” 
neurocognitive measures of executive functioning (EF) in adults with substance use disorder 
(SUD) (Hagen et al., 2016) 
Patients with polysubstance use disorder (PSUD) and healthy controls were compared on 
hot (Iowa Gambling Task) and cold (Stroop and the Trail Making Test) measures of EF, and 
participants completed a questionnaire assessing everyday EF-related problems (the Behavior 
Rating Inventory of Executive Function–Adult self-report version (BRIEF-A). To our 
surprise, the psychometric measure of hot EF (the Iowa Gambling Task) did not differentiate 
the patients with PSUD from controls and was not associated with any of the social adjustment 
indicators. The psychometric measures of cold EF differentiated somewhat between the 
groups and were associated with one indicator of social adjustment. However, the BRIEF-A 
differentiated between groups on all the clinical scales and was associated with three out of 
five social adjustment indicators. We concluded that the BRIEF-A was the most sensitive 
measure of EF in patients with SUD and should, therefore, be considered as a fundamental 
part of the clinical routine when assessing patients with SUD. 
PSUD is the most common diagnosis among patients seeking treatment for substance use. 
Compared with single-drug users, polydrug users have an earlier debut of drug use, a higher 
rate of dropout from treatment, and they report higher levels of general psychological distress; 
this psychiatric comorbidity increases the risk of relapse. Studies have shown that impaired 
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psychiatric and cognitive functioning also greatly diminishes patients’ subjective perception 
of satisfaction with life. Even though satisfaction with life is reduced among SUD patients, it 
has not been thoroughly investigated in patients with PSUD. As satisfaction with life is 
described as an essential motivator for and predictor of successful treatment, it should be 
included as a key outcome indicator when evaluating the success of SUD treatment. Thus, 
paper II investigates whether individuals with PSUD who achieve at least one year of 
abstinence show greater improvement in satisfaction with life, executive functioning, and 
psychological distress compared with those who relapse and controls. Results indicated that 
participants who successfully abstained from substance use for one year showed improved 
satisfaction with life, executive functioning, and psychological distress compared with 
participants who relapsed and controls. Our findings suggest that a gradual and careful 
increase of learning requirements should be implemented, and SUD treatment should initially 
concentrate on stabilizing the patient and achieving abstinence, while interventions for 
comorbid problems and more cognitively challenging treatment components are more likely 
to succeed later in the treatment sequence (Hagen et al., 2017). 
Attention-deficit/hyperactivity disorder (ADHD) is a common comorbid disorder among 
patients suffering from SUD. Compared with SUD patients without ADHD, SUD patients 
with ADHD are more likely to have developed SUD at a younger age, become polysubstance 
users, and need inpatient treatment more often. It is well established that the prefrontal cortex 
is involved in reward mechanisms, emotional processing, and behavioral inhibition, as well as 
drug use susceptibility. These functional areas have also been associated with the development 
of ADHD, and thus these two disorders could share a preexisting neurobiological 
vulnerability. Hence, the possible overlap and interconnections between these disorders are 
relevant to both research and clinical practice. Paper III investigates whether individuals with 
PSUD with one year of abstinence show a reduction in ADHD symptoms compared with those 
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who relapse and controls. ADHD symptoms were measured using the adult ADHD Self-
Report Scale (ASRS). Substance use was evaluated by self-reports on the Alcohol Use 
Disorders Identification Test (AUDIT) and the Drug Use Disorders Identification Test 
(DUDIT). Results indicate that patients who remained abstinent for one year reported a 
substantial reduction in ADHD symptoms compared with patients who relapsed and controls. 
We concluded that confirmation of an ADHD diagnosis should follow a period of abstinence 
to avoid identification of false-positive cases (Hagen et al., 2017)  
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1. Introduction- Background 
Providing effective treatment for vulnerable groups with extensive disease burden, such 
as patients with SUD, represents a major societal challenge. This PhD project aims to shed 
light on the initial assessment of cognitive impairment among SUD patients, as well as the 
recovery process in the year after initiation of a new treatment sequence. To ensure a diverse 
and clinically relevant picture of the dimensions underlying recovery, we have broadened the 
scope of interest to include measures of satisfaction with life, psychological distress, and 
ADHD symptomatology, as well as neurocognitive functioning. Our hope is that this project 
will contribute to more effective substance use treatment programs, both for the patients and 
for society in general. 
1.1 The neurocognitive substrate of addiction 
Alcohol and drug abuse impacts neurocognitive functioning directly by producing changes 
in neurochemistry, and indirectly by affecting other organ systems, particularly the liver. The 
primary mechanism is associated with neurobiological changes that develop from initial 
positive reinforcement mechanisms to loss of control, the emergence of negative emotional 
states when access to intake is obstructed, and sensitized (hypersensitive) responses involving 
compulsive drug intake (Koob, 2008; Leshner, 1997; Robinson & Berridge, 2008). 
Chronic substance use can induce changes in synaptic functioning, either by modifying 
receptor sensitivity, or by changing the synaptic reuptake process, and these require time to 
stabilize after psychoactive substance intake has finished. Studies have focused on the specific 
neural pathways involved in mediating and modulating the positive reinforcing effects of 
drugs, and how these connect to the regulation of reward processes. It is proposed that there 
are strong conditioning patterns within subcortical circuitry involving a dopaminergic tract 
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that connects the nucleus accumbens to the ventral tegmental area (VTA), and then back to 
the nucleus accumbens, prefrontal cortex, and amygdala. This process drives the initial 
hedonic mechanism (liking) toward obsessive drug-seeking behavior (wanting), and this 
nonreflective compulsion could represent a causal mechanism initiating relapse even after 
extended periods of abstinence (Everitt, Dickinson, & Robbins, 2001; Robinson & Berridge, 
2008; Tomkins & Sellers, 2001). Repeated use modifies dopamine production, resulting in the 
dysregulation of brain reward circuitry, and subsequently creating the subcortical biological 
basis for the addiction (Koob, 2009). 
Reward mechanisms have progressively been linked to other neurotransmitter pathways 
connecting the mesolimbic structures to cortical areas of the brain, and to the prefrontal cortex 
(PFC). Addictive behavioral patterns are reinforced by sensitized and overactive mesolimbic 
circuitry, in combination with a weakened executive control of prefrontal cortex (Bechara et 
al., 2001; Rogers & Robbins, 2001; Schoenbaum & Shaham, 2008; Stalnaker, Takahashi, 
Roesch, & Schoenbaum, 2009). 
PFC impairments have been linked to dysfunctional impulse control, response inhibition, 
decision-making, and poor goal-driven behavior. Central components are reduced ability to 
suppress responses, poor attention, poor evaluation of consequences, and a predisposition to 
short instantaneous rewards over greater and delayed rewards (Cardinal, Winstanley, Robbins, 
& Everitt, 2004). These impairments have all been associated with addiction (Bechara, Dolan, 
& Hindes, 2002). 
Historically, decision-making and higher-order executive functions (EF) have been 
understood and investigated as rational and “cool” cognitive processes, predominantly 
involving the dorsolateral prefrontal cortex (E. K. Miller & Cohen, 2001; Zelazo, Craik, & 
Booth, 2004). “Cold” EF involves abstract, context-independent tasks without strong 
emotional or motivational features (e.g., updating, flexibility). “Hot” executive functions 
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involve, to a larger degree, stimuli and decisions with a more distinct emotional or 
motivational salience, such as inhibition, emotional control and self-regulation (Kerr & 
Zelazo, 2004) 
“Hot” EF has increasingly been linked to the orbitofrontal cortex (OFC) (Anderson, 
Barrash, Bechara, & Tranel, 2006; Kerr & Zelazo, 2004). This region is a part of the prefrontal 
cortex, and shares distinctive circuitry with specific subcortical limbic learning areas involving 
the basolateral amygdala and nucleus accumbens, consequently giving this region a vital role 
in enabling associative information regarding outcomes and likely consequences to access 
working memory. The OFC has circuitry with essential sensory modalities, including 
gustatory, olfactory, somatosensory, auditory, and visual modalities (Carmichael & Price, 
1995). Because it integrates sensory and visceral motor information, in collaboration with its 
connections with the basolateral amygdala, the OFC has an important role in emotional 
processing (Nauta, 1971) and goal-directed behavior. Deficiencies in these OFC functions will 
disrupt the ability to make adaptive decisions and to learn from the negative consequences of 
decisions. Research indicates similarities between patients with OFC lesions and patients with 
SUD; both groups exhibit reduced sensitivity to future consequences, and impaired decision-
making in real-life situations (Bechara et al., 2001). These impairments are present even after 





1.2 SUD, neurocognitive impairments and implications for 
treatment 
Estimates of the prevalence of cognitive deficits among alcohol and drug abusers who seek 
treatment vary significantly from 30% to 80% (Bates, Bowden, & Barry, 2002; Copersino et 
al., 2009). Cognitive impairment has an impact on the quality of life, occupational functioning, 
and the ability to profit from therapy, and thus affects the course of rehabilitation and level of 
community integration among patients with SUD (Fernandez-Serrano et al., 2011). 
Even though the results are not conclusive, findings indicate that neuropsychological status 
serves as a moderator or mediator of treatment outcome, rather than representing a direct 
causal relationship (Aharonovich et al., 2006; Aharonovich, Nunes, & Hasin, 2003; W. Fals-
Stewart & Schafer, 1992). More specifically, cognitive impairments have been shown to have 
a negative effect on treatment adherence (Bates, Pawlak, Tonigan, & Buckman, 2006) and 
attendance at outpatient therapy sessions (Guthrie & Elliott, 1980), to reduce change 
willingness (Blume & Marlatt, 2009), reduced self-insight (Horner, Harvey, & Denier, 1999), 
increased denial of substance abuse (Rinn, Desai, Rosenblatt, & Gastfriend, 2002) and 
increased impulsivity (Clark, Robbins, Ersche, & Sahakian, 2006; Crews & Boettiger, 2009) 
Several studies have found that cognitive impairment is associated with poorer treatment 
outcome, including decreased treatment retention (Aharonovich et al., 2006; William Fals-
Stewart, 1993), and less abstinence from the abused substance after treatment termination 
(Aharonovich et al., 2006). This raises the possibility that negative psychological features 
previously accredited to clients, such as denial of problem severity and the dearth of 
motivation and impulsivity, may derive from specific neuropsychological insufficiencies, 
rather than other psychological and psychosocial factors (William Fals-Stewart, 1997). 
Historically, the conceptual model of the treatment for SUD has been similar to that for 
the treatment of acute medical conditions, assuming that patients entering addiction treatment 
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should maintain abstinence following a preferably single episode of treatment (McLellan, 
Lewis, O'Brien, & Kleber, 2000). Unfortunately, this perspective has not yielded promising 
treatment outcomes. Evidence shows that most alcohol- and drug-dependent patients relapse 
following cessation of treatment (N. S. Miller, Ninonuevo, Klamen, Hoffmann, & Smith, 
1997). Findings indicate that up to 50–60% of patients relapse within six months of treatment 
cessation, regardless of patient characteristics, type of discharge, or type of addictive drug 
(Hunt, Barnett, & Branch, 1971; McKay et al., 1997; McKay et al., 2004). Chronic users who 
continue to abuse alcohol or other drugs despite increasing negative consequences represent 
the most rigid and impaired subgroup facing treatment (Shaffer & Zinberg, 1985). For this 
subgroup, addiction progresses into a recurring illness requiring repeated treatment initiatives 
before patients reach long-term abstinence (McLellan et al., 2000). Consequently, diagnosing 
and treating patients with SUD involve a complexity of clinical challenges and considerations 
that are becoming increasingly more problematic, and efforts should be made to identify 
predictors to enhance recovery and treatment outcomes. 
Evidence indicates that patients’ self-reports of cognitive functioning do not give an 
accurate picture of neurocognitive status, and seem to be more closely associated with 
emotional distress than reflecting the level of cognitive functioning (Shelton & Parsons, 1987). 
The onset of cognitive deficits is slow and gradual, which could help mask patients’ 
deteriorating functioning (Horner et al., 1999). Studies have also shown that therapists cannot 
subjectively identify and assess SUD patients’ cognitive status (William Fals-Stewart, 1997). 
Even though there is evidence indicating that this impairment will gradually improve 
spontaneously during the first six months of sobriety, patients may not be in treatment long 
enough to achieve significant cognitive improvement. This creates a situation where 
spontaneous recovery may be too late to be of any real consequence concerning treatment 
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outcome. Thus, therapy may occur at a time when a person has the most pronounced cognitive 
impairments and has the least ability to benefit from it (Vocci, 2008). 
The relevance of these findings is amplified by treatment procedures based on the 
assumption that the patient has the cognitive capacity to pay attention, assimilate additional 
information, integrate this with preexisting cognitive structures, and can use this for behavioral 
change (Goldman, 1990; Grohman & Fals-Stewart, 2003). Regardless of theoretical 
foundation, most therapeutic interventions for SUD (i.e., cognitive behavioral therapy, 
motivational interviewing, and 12-step programs) are verbally based interventions requiring 
extensive cognitive processing to facilitate cognitive, motivational, and behavioral change 
(Roehrich & Goldman, 1993). For instance, a common feature of most treatment initiatives 
involves learning the harmful effects of various drugs, as well as program rules and the 
overarching treatment philosophy (Grohman & Fals-Stewart, 2003). 
It is well known that neurocognitive assessment services are scarce, costly, and generally 
unavailable to SUD patients. Hence, it is critical to develop, evaluate, and apply testing 
procedures that could be made more readily available in a busy clinical setting. This was the 
motivation for the current project, particularly in paper 1 where we focused on comparing the 
utility of psychometric tests and a questionnaire-based inventory to assess “hot” and “cold” 
neurocognitive measures of EF in adults with SUD. Paper II and III had a longitudinal design 
and aimed to explore the recovery process, particularly among patients who manage to stay 
sober for a period of one year, as measured by a broad array of output indicators. 
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2. Aim and research questions 
 
1. The need for clinic-friendly neurocognitive measures was the motivation for Paper I. 
We investigated two theoretical EF components, referred to as “cold” and “hot” EF, in 
a group of patients with SUD. This included psychometric performance tests and a 
questionnaire-based inventory. With an aim to document EF impairment in patients 
with SUD of importance to real-life social adjustment, paper I compared performance-
based measures and a questionnaire-based inventory. We investigated their efficiency 
in characterizing the SUD patients when compared to a control group.  
  
2. Several studies have found a co-occurrence between mental distress and dose-related 
polydrug use and a reduction of mental distress among abstinent patients. However, 
focus on a broader spectrum of output indicators was needed to shed light on the 
recovery process for this important and highly vulnerable subgroup of SUD patients. 
Paper II featured a prospective design and a control group, and was used to address the 
following question. Will individuals with polysubstance use disorder who achieve at 
least one year of abstinence show greater improvement in satisfaction with life, 
executive functioning, and psychological distress than those who relapse and controls? 
 
3. ADHD is a common comorbid disorder in patients suffering from SUD. ADHD has an 
adverse consequence on the course of SUD, and SUD patients with comorbid ADHD 
have an increased risk of developing SUD at a younger age, and become polysubstance 
users, and need inpatient treatment more often than SUD patients without ADHD. 
Paper III investigated changes in self-reported ADHD symptoms in people with 
polysubstance use disorder during the year following the initiation of treatment. Using 
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a prospective design and a control group, we addressed the following question. Will 
individuals with polysubstance use disorder who remain abstinent for one year show 




3. Design, material, and methods 
3.1 Research challenges 
Research within this field is faced with several interpretive challenges as to the origins of 
cognitive deficits associated with SUD. Psychiatric comorbidity, medical risk factors (head 
trauma, HIV – malnutrition, overdoses), genetic predispositions, premorbid vulnerability 
(genetic, psychosocial and environmental), co-occurring use of multiple drugs, could all play 
a significant part in the causal factors leading to the current neuropsychological impairment 
profile. Many of the extensive RCT studies within this field have excluded clients with 
comorbid conditions, polydrug use, etc. Consequently, findings could be based on a client 
sample that does not portray the heterogeneity in the patient population. We wish to avoid this 
by including patients with comorbid conditions as well as polydrug use and also to establish 
the necessary logistics to follow patients in the study even if they drop out of treatment. 
As mentioned previously there is generous evidence of an association between various 
aspects of SUD and cognitive impairment, but the direct versus the indirect role of the different 
substances are not clear.  Theoretically, several cognitive deficits could be viewed as 
antecedents to the onset of SUD, especially involving executive functions connected to long-
term decision making and impulsivity  (Nigg, Blaskey, Huang-Pollock, & Rappley, 2002; 
Nigg et al., 2006). However, the aim of paper I is not to address the source of executive 
impairments, but to assess different assessment methods at an early clinical evaluation, and to 
investigate their efficiency in characterizing the SUD group, and several social adjustment 
indicators, when compared with a control group. Likewise, the two next papers are dealing 
with recovery of executive and psychological functioning throughout one-year and do not 
focus on the origin of cognitive symptoms.  
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Previous treatment studies of impaired cognitive functions in SUD patients have several 
limitations. They have primarily dealt with the acute and subacute effects of chronic alcohol 
and drug use (Fernandez-Serrano et al., 2011; Vik, Cellucci, Jarchow, & Hedt, 2004; Yucel, 
Lubman, Solowij, & Brewer, 2007), and studies of long-term recovery do not always require 
a 14-day drug-free period prior to baseline testing (Fernandez-Serrano et al., 2011). Other 
studies have small sample sizes, often with a focus on patients with one primary addiction 
(Badiani, Belin, Epstein, Calu, & Shaham, 2011; Buelow & Suhr, 2009; Stavro, Pelletier, & 
Potvin, 2013). Also, many studies have used cross-sectional designs and are therefore unable 
to track changes in individual patients over time (van Holst & Schilt, 2011). There is also 
considerable variability in the follow-up rates, ranging from 40% to 98% (Cottler, Compton, 
Ben-Abdallah, Horne, & Claverie, 1996; Desmond, Maddux, Johnson, & Confer, 1995; 
Stinchfield, Niforopulos, & Feder, 1994), and some studies have not included a follow-up 
procedure for a control group (Schulte et al., 2014).  
A key challenge in this study has been to retain patients over a period of one-year.  
Previously considerable variability has been reported on the follow-up rates from patients with 
SUD, ranging from 40 to 98 % (Cottler et al., 1996; Desmond et al., 1995; Stinchfield et al., 
1994).  This significant disparity in retention complicates not only our ability to make accurate 
statistical power estimates of the number of participants needed but could, if not dealt with – 
impact our ability to draw conclusions and generalizations from our investigation. We have 
applied a diversified strategy to retain participants, ranging from contact and scheduling 
measures, SMS reminders, financial incentives, and flexibility in procedures and visit 
characteristics. For a detailed description of the follow-up procedures in the project see 
Svendsen et al. (Svendsen et al., 2017). 
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3.2 Design, recruitment and data collection 
The studies were all part of a prospective, longitudinal cohort study of a SUD patient 
sample who started a new treatment sequence in the Stavanger University Hospital catchment 
area. The three papers present data collected from SUD patients admitted to both outpatient 
and residential treatment facilities. To minimize contamination from drug withdrawal and 
acute neurotoxic effects from psychoactive substance, participants were tested after two weeks 
of abstinence (L. Miller, 1985). The project was approved by the Regional Ethical Committee 
(REK 2011/1877). 
3.3 Paper I: Participants and procedures 
One hundred and fifty participants were recruited from outpatient and residential 
treatment facilities within the region, across ten enrollment sites. Patients were recruited 
between March 2012 and May 2013. Consecutive enrollment continued until the required 
number of participants were recruited. The SUD group included patients reporting use of more 
than one drug at a single occasion or a history of having injected or abused multiple drugs, 
based on responses to the Alcohol Use Disorders Identification Test (AUDIT) (Bohn, Babor, 
& Kranzler, 1995) and the Drug Use Disorders Identification Test (DUDIT) (A. C. Voluse et 
al., 2012).  Five patients were excluded due to not having a substance-related addiction. One 
patient was excluded due to only using cannabis, one due to only using opioids, and 14 due to 
only using alcohol. The control group (n = 38) was a convenience sample recruited using 
posters at social welfare and primary care offices. Controls and patients were offered 
compensation of NOK 400 for baseline testing. Nine patients (seven 17-years of age, two 16-
years of age) were excluded due to age. The final group consisted of n = 126 SUD patients 
and n = 32 controls.  
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3.3.1 Inclusion procedure 
To be eligible for admission to the study, patients needed to: a) sign a written informed 
consent to participate; b) embark on a new treatment sequence within the substance abuse 
treatment service, and c) be at least 18 years of age. Patients also had to have been enrolled in 
the program to which they were admitted for at least two weeks, and abstinence was verified 
through self-report, for both inpatients and outpatients. In one of the first treatment sessions 
(1–3), patients were given an information sheet with a short project description. 
3.3.2  Measures 
Cold EF were measured with the computerized Stroop test (Stroop CW) (Golden & 
Freshwater, 1978). Stroop is an assessment of attention, interference, and inhibition of 
dominant responses (MacLeod, 1991). Another measure of cold EF is the Trail Making Test 
(TMT) (Kortte, Horner, & Windham, 2002; Strauss, Allen, Jorgensen, & Cramer, 2005). TMT 
provides data on visual-conceptual and visual-motor tracking and set shifting. Longer time to 
finish indicates impairment. 
Hot EF was examined using the Iowa Gambling Task (IGT) (Bechara, Damasio, 
Damasio, & Anderson, 1994). The key task in the IGT is to make advantageous long-term 
decisions in conditions of uncertainty. For this test, subjects are given $2,000 to start, and their 
task is to maximize profit across 100 trials by choosing cards from one of four decks. After 
ten selections from decks A and B, the subject will have earned a net loss of $250, whereas 
decks C and D result in a net gain of $250. Consequently, decks A and B are the “risky” decks. 
It is assumed that the perception of risk within the IGT increases across trials, as subjects gain 
experience with the win/loss contingencies in the various decks (i.e., later trails have stronger 
emotional, or risky, associations) (Brand, Recknor, Grabenhorst, & Bechara, 2007). 
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The BRIEF-A is a self-report questionnaire composed of nine subscales and three 
composite scores. The Behavioral Regulations Index (BR-index) consists of the subscales 
Inhibit, Shift, Self-Monitor, and Emotional-Control. The subscales Initiate, Plan/Organize, 
Working Memory, Organization of Materials, and Task-Monitor comprise the Metacognition 
Index (MI). The BRI and MI can be combined to produce the overall Global Executive 
Composite (GEC). Validity scales were examined, and two controls-  and ten SUD participants 
profiles were excluded due to invalid response styles. 
Specific information on substance abuse was based on self-reported responses on the 
AUDIT (Bohn et al., 1995) and the DUDIT (A. C. Voluse et al., 2012). The Wechsler 
Abbreviated Scale of Intelligence (WASI) was included as a control variable because there 
was a significant difference between controls and SUD patients in the univariate analysis, and 
to ensure that EF deficits could not be attributed to general abilities. An interview based on 
items from the preliminary version of the National Quality Register for Substance Abuse 
Treatment was used to collect demographics, type of addiction, initial age at use, treatment 
and work history, educational, and vocational data. Social adjustment scores were obtained 
based on a yes/no responses and included the following categories: permanent housing, 
criminal lifestyle, conflict with caregivers, friends outside the drug environment, and stable 
income. 
3.3.3  Analysis 
Binary logistic regression analyses (enter method) were applied to assess independent 
correlates of SUD status and categorical variables indicating social adjustment. In these 
analyses, control variables (age, sex, years of education, and WASI Total IQ), and raw scores 
from the cold EF, hot EF, and BRIEF-A BRI and MI were sequentially entered into the 
analyses. A multiple linear regression was performed to predict the number of previous 
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treatment attempts. As a quantified measure of goodness-of-fit, Nagelkerke’s R2 was 
estimated and reported. Due to the significant difference in WASI total IQ between controls 
and patients, WASI total IQ was included in a control variable in these analyses.  
3.4 Paper II 
This study used the same cohort and the same inclusion procedure as the first study and 
compared development from baseline to 12-months follow-up. At the one-year follow-up, 
patients were defined as relapsing to a significant level of use if they had an AUDIT score 8 
or DUDIT score 2 for women and 6 for men (Bohn et al., 1995; Andrew C Voluse et al., 
2012). 
3.4.1 Measures 
3.4.2 Satisfaction with Life  
Satisfaction with life was assessed baseline and one year later with the Satisfaction With 
Life Scale (SWLS) (Diener, Emmons, Larsen, & Griffin, 1985). This is a self-report 
questionnaire including five items measuring the global life satisfaction experienced by the 
respondent. The SWLS has demonstrated good psychometric characteristics (Pavot & Diener, 
2008). 
3.4.3 Executive Functions  
This study assessed executive functions by asking the participants to complete the 
Behavior Rating Inventory of Executive Function-Adult version (BRIEF-A) (Gioia, Isquith, 
Guy, Kenworthy, & Baron, 2000; Roth, Isquith, & Gioia, 2005) at baseline and one year later. 
The BRIEF-A has been shown to have high ecological validity (Gioia et al., 2000; Roth et al., 
2005), and to be associated with substance use status as well as several social adjustment 
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indicators in patients with a history of PSUD. The BRIEF-A includes three composite scores 
including sets of subscales. A Behavioural Regulation Index (BRI-index) is calculated from 
the Inhibit, Shift, Self-Monitor and Emotional Control subscales. The BRIEF-A 
Metacognition Index (MI) is calculated from the Initiate, Plan/Organize, Working Memory, 
Organization of Materials, and Task Monitor subscales. Validity scales of the BRIEF-A were 
examined, using the cut-off scores proposed by the original authors (Gioia et al., 2000). Invalid 
response style led to the exclusion of one control and nine SUD participants at baseline, and 
three controls and five SUD participants at the one-year follow-up. The final sample included 
the 30 controls and 101 SUD patients with valid BRIEF-A protocols.  
3.4.4 Intellectual functions 
The Wechsler Abbreviated Scale of Intelligence (WASI) (Wechsler, 1999) was used to 
estimate intellectual function (IQ) by including two tests of verbal crystallized abilities 
(Vocabulary and Similarities) and two tests of nonverbal fluid-visual abilities (Block Design 
and Matrices) (Canivez, Konold, Collins, & Wilson, 2009). 
3.4.5  Psychological distress  
Psychological distress was measured at baseline and one year later using the Symptom 
Checklist-90-R (SCL-90-R) (Derrogatis, 1994). This is a 90-item self-report symptom 
inventory that yields measures of nine symptom domains of psychological distress. This study 





3.4.6 Statistical Analyses 
Group differences were analyzed using t-tests, Mann–Whitney U tests, and Pearson’s chi 
square-tests when appropriate. Levene’s test was used to select the appropriate p-values based 
on whether the assumption of equal variances within groups was met. Histograms, Q–Q plots, 
Kolmogorov–Smirnov tests, and Shapiro–Wilk tests were used to investigate normality. 
The research question was analyzed using mixed between-within subjects’ ANOVA to 
compare changes in abstainers, relapsers, and controls from the baseline to the one-year 
follow-up. Variables, where the three groups have similar patterns of change from baseline to 
one year, will not have a statistically significant interaction effect (the null hypothesis). 
Variables, where one group has a different pattern of change from the other two groups, are 
expected to show an interaction. To determine the cause of interaction effects, Wilcoxon 
signed rank tests were used to evaluate median change from baseline to one year within each 
group. Effect sizes were calculated as Cohen’s r for nonparametric data, where 0.3 is 
considered a medium and 0.5 is considered a large effect (Cohen, 1988). Main effects were 





3.5 Paper III 
3.5.1 Participants and procedures 
Same as article two 
3.5.2 Measures 
3.5.3 Adult ADHD Self-Report Scale (ASRS) 
The ASRS is a frequently used screening instrument for ADHD (Kessler et al., 2005). It 
is composed of 18 items that reflect the symptoms used to define ADHD according to the fifth 
edition of the Diagnostic and statistical manual of mental disorders (DSM-V) (Association, 
2013). The results from this scale assess the presence of ADHD symptoms, but on its own, it 
is not an adequate diagnostic tool. 
Symptoms are rated on a 5-point Likert-type scale (0–4 = never, rarely, sometimes, 
often, and very often), with a range of 0 to 72 for the 18-item instrument. This instrument has 
previously been validated in SUD populations (Dakwar et al., 2012; Van de Glind et al., 2013). 
In this study, we included a sum score across all the 18 ASRS items, a sum score for the 
ASRS items that assess inattention (items 1–4 and 7–11), and a sum score for the items that 
assess hyperactivity/impulsivity (items 5, 6, and 12–18).  
To highlight the severity of individual items in the ASRS, we dichotomized responses 
to the ASRS items into “severe/not severe” according to recommendations by Kessler et al. 
(Kessler et al., 2005).  Lastly, we used the "severe/not severe" dichotomized items to identify 
clinically significant ASRS profiles. The ASRS profile was dichotomized as "clinically 
significant" if  9 items were dichotomized as “severe”, and "not clinically significant if <9 
items were dichotomized as severe". This method is commonly used in clinical practice, and 
in line with the original recommendations by Kessler et al. (Kessler et al., 2005).  
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3.5.4 Statistical analyses 
Data were assessed for normality with histograms, Q–Q plots, Kolmogorov–Smirnov 
tests, and Shapiro–Wilk tests. Visual inspection of histograms and Q-Q-plots revealed that 
ASRS-scores at baseline and one-year follow-up did not deviate from normality. This was also 
evident from the Kolmogorov-Smirnov test (D(149) = 0.05, p = 0.200; and 1 year D(149) = 0.06, 
p=0.200, respectively) and Shapiro-Wilk test (baseline w(149) = 0.99, p=0.651; and 1 year w(149) 
= 0.99, p=0.327). Sub-analysis of normality for each participant group yielded similar results. 
As the data were normally distributed, parametric statistics were used throughout. Mixed 
ANOVA was used to compare changes in abstainers, relapsers, and controls from baseline to 
the one-year follow-up. Variables for which one group’s responses differed from those of the 
other two groups were expected to show a significant interaction. To determine the cause of 
interaction effects, a paired samples t-test was used to evaluate mean change from baseline to 
one-year within each group. Effect sizes were calculated as Cohen’s d for paired samples and 
parametric data, where 0.5 was considered a medium effect and 0.8 was considered a large 
effect (Cohen, 1988). Main effects were not interpreted in the presence of a statistically 
significant interaction (Bordens & Abbott, 2002). 
Lastly, the frequency of individual items dichotomized as severe was estimated for each 
group (i.e., abstinent, relapsed, and control), and changes in frequency during the one-year 
follow-up were investigated for each item using a repeated measures ANOVA. As multiple 
comparisons were made, Bonferroni adjusted P-values (0.05/18 = 0.003) were used to 




4.1 Paper I 
The psychometric test of hot EF (the Iowa Gambling Task) did not discriminate patients 
with PSUD from controls and was not related to social adjustment. The psychometric tests of 
cold EF distinguished to some extent between the groups and were associated with one 
indicator of social adjustment. The BRIEF-A differentiated between groups on all the clinical 
scales and was associated with three out of five social adjustment indicators (“criminal 
lifestyle,” “conflict with a caregiver,” and “stable housing.”). 
4.2 Paper II 
Executive functions (EF) measured by the self-report instrument BRIEF-A improved 
in the group of abstinent patients between baseline and one-year, but this was not the case with 
the patients that relapsed.  Improvement of EF is very promising, considering that maladaptive, 
impulse-driven behavior is strongly associated with a substance using lifestyle (Crews & 
Boettiger, 2009). Notably, in spite of the improvement in EF in the abstainers, they still 
reported somewhat reduced function compared with controls, which indicates that they still 
had some degree of susceptibility related to impaired EF, even after a year of abstinence. 
Psychological distress also decreased in the abstinent group. At the one-year follow-up, the 
discrepancy between the abstinent group and the controls almost vanished, suggesting a 
normalization of psychological distress following one year of abstinence. This finding is in 
line with previous research that has found a reduction of psychological distress among 
patients who stopped using multiple drugs (Andreas, Lauritzen, & Nordfjærn, 2015). 
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However, it should be emphasized that the second study focuses on a broader spectrum of 
output indicators than previously reported. 
There was also a significant difference in perceived satisfaction with life as measured 
by SWLS between the abstinent and relapse groups after one year. The importance of this 
finding is substantiated by previous studies showing an association between satisfaction with 
life and subsequent symptoms in recovery, where satisfaction with life increases through early 
recovery to stable abstinence (Laudet, Morgen, & White, 2006).  
4.3 Paper III 
The third paper compared patients with PSUD who remained abstinent, patients who 
relapsed, and healthy controls on changes in self-reported ADHD symptoms from baseline to 
follow-up assessment one-year later. The abstinent group showed a substantial reduction of 
ADHD symptoms compared with the relapse and control groups. In fact, the scores of the 
abstinent group at follow-up were only slightly higher than those of the healthy controls, who 
were in the normal range for ADHD symptoms at both baseline and follow-up. The 
improvements in the abstinence group were particularly prominent on the ASRS items that 




5.1  Discussion and conclusions 
5.2 Paper I 
Several studies have supported the validity of the BRIEF scales and other rating scales 
in assessing every-day executive functioning (Isquith, Roth, & Gioia, 2013). Responses on 
BRIEF-A was significantly raised on all the nine scales for SUD patients compared to the 
controls. Previous studies have found similar outcomes, where patients with PSUD report 
significantly more executive dysfunctions on BRIEF-A, compared to non-users 
(Hadjiefthyvoulou, Fisk, Montgomery, & Bridges, 2012).  
The PSUD group performed slightly (but not significantly) better on the hot EF, 
measured by the IGT total score. Functional impairments based on IGT have been found in 
individuals with alcohol, cocaine, and opioid use disorders, relative to healthy controls 
(Bartzokis et al., 2000; Bechara & Damasio, 2002; Bechara et al., 2001). However, findings 
are not conclusive, and some studies have shown that groups of healthy controls do not learn 
to successfully select cards from the advantageous decks, and also showing high variance in 
anticipatory electro-dermal responses (Dunn, Dalgleish, & Lawrence, 2006). The opposing 
findings from some studies, where controls perform poorly on IGT while not showing any 
deficiencies in real-life decision-making, makes it uncertain whether IGT performance have 
predictive value on real-life functioning. 
Similar to our findings, it has proven difficult to establish associations between 
neuropsychological performance tests and rating scales of EF, and this has raised questions 
whether the two assessment approaches address different cognitive functions or different 
applications of cognitive skills (Isquith et al., 2013; McAuley, Chen, Goos, Schachar, & 
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Crosbie, 2010). Isquith, Roth, and Gioia (2013) offer a possible frame of clarification where 
neuropsychological performance tests are hypothesized to assess cold aspects of EF, and rating 
scales address a hot emotional aspect of EF. With regards to the BRIEF-A, this hypothesis 
draws support from research that has applied confirmatory factor analysis of the BRIEF-A 
scales and detected a distinct emotional regulatory factor, involving of the Emotional Control 
and Shift scales (Gioia, Isquith, Retzlaff, & Espy, 2002). Studies have questioned if the BR 
index is, in fact, a measure of hot EF, in contrast to the less emotive items constituting the 
remaining scales (Egeland & Fallmyr, 2010). This distinct hot factor, in BRIEF, has been 
replicated in several studies (McCandless & O' Laughlin, 2007; Peters, Algina, Smith, & 
Daunic, 2012). On the other hand, a recent study, (Skogli, Egeland, Andersen, Hovik, & Øie, 
2014) on hot and cold EF in ADHD found no correlation between any of the BRIEF scales 
and performance-based measures of hot performance EF. The correlation matrix displayed a 
marginally higher correlation between cold EF tests and cold BRIEF scales than with the hot 
BRIEF scales. Overall cold BRIEF scales reached moderate correlation with cold EF tests. To 
our knowledge, the majority of these findings have been based on studies of with Attention 
Deficit Hyperactivity Disorder, and we have not succeeded in finding previous studies 
investigating associations between neuropsychological performance tests and rating scales of 
EF in adult SUD samples. 
4.2 Social adjustment 
BRIEF-A was associated with SUD as well as some indicators of social adjustment in SUD 
patients. Even when controlling for significant demographic variables, the BRI in BRIEF-A 
was associated with several domains of social adjustment, where increased scores on the BRI 
of the BRIEF-A were related to both substance abuse and lower social functioning. The BRI 
consists of four subscales crucial for real-life adaptive social behavior, which offers a plausible 
explanation for our findings. The Inhibit scale assesses the ability to assert impulse control 
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(go/no-go), and to what extent one can inhibit, stop or adjust one’s behavior when called for 
by the circumstances. The Shift scale assesses one’s ability to flexibly adjust to alternating 
situations, tasks or aspects of challenges. The Emotional control scale assesses one’s ability to 
regulate the expression of emotional responses, while the Self-Monitor scale assesses 
interpersonal awareness and to which extent one understands how one’s behavior affects 
others (Roth et al., 2005). The BRIEF-A questionnaire measure participant’s subjective 
evaluation of their function in real-life situations and our findings suggest that the BRIEF-A 
have a higher ecological validity than results obtained on performance-based tests. 
We did not find any association between performance-based assessment of hot or cold 
EF and SUD, or social adjustment in the SUD group. There is a lack of studies detailing the 
link between performance-based measures of hot and cold EF in SUD and their relationship 
with social adjustment. However, regarding neurocognitive predictors of social adjustment, 
studies of patients with closed brain injury indicates that impairments in overall social 
adjustment (occupational status, leisure activities, social contacts and family life), are closely 
linked to the severity of the damage and subsequent cognitive sequela, (Oddy, Coughlan, 
Tyerman, & Jenkins, 1985). 
Our findings suggest that representative and frequently used neurocognitive 
performance-based assessments might render a false negative conclusion in an initial 
evaluation, while a questionnaire-based self-evaluation is associated with impaired social 
adjustment and substance abuse. The lack of relationships between self-rating measures and 
performance-based measures of EF could imply that they measure different aspects of 
executive functions, and some suggest that performance measures are particularly sensitive 
to components of executive functions in isolation, while rating scales assess the application 
of those skills, (Isquith et al., 2013). It has been argued that traditional neuropsychological 
tests artificially fractionate an integrated functional network (Burgess, 1997) and that the 
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operationalization and types of methods used to measure EF impact the conclusions and 
interpretations we can make.   
Our results indicate that IGT and BRIEF-A BRI assess two different cognitive 
constructs. IGT is presumably sensitive to subtle, unconscious perceptions of somatosensory 
feedback or “hunches” to guide decision-making, whereas the BR index from BRIEF-A 
captures the responder's own view of his or her ability to maintain appropriate control of their 
behavior and emotional responses (Roth, Isquith, & Gioia, 2005). This is supported by recent 
findings showing only minimal correlations between the two types of measures (Toplak, West, 
& Stanovich, 2013), providing further support for the hypothesis that there are separate EF 
pathways measured by IGT versus BRIEF-A (Sonuga-Barke, 2003). 
5.2.1 Conclusion 
The BRIEF-A inventory was the most sensitive measure to identify group affiliation and 
social adjustment among patients with PSUD, followed by measures of cold EF. It is well 
known that neurocognitive assessment services are scarce, expensive, and unavailable to SUD 
patients. Hence, it is crucial to develop, evaluate, and apply testing procedures that could be 
made more readily available in busy clinical settings and that could also be administered by a 
broader array of professions. Our data indicate a promising potential for inventory-based EF 
assessment in SUD patients as measured by BRIEF-A. Self-report measures of EF can be 
valuable, cost-effective, and accurate at an initial clinical evaluation, providing important 
complementary measures to performance-based tests.  
5.3 Paper II 
The multimodal improvement of satisfaction with life and self-reported executive 
functions and the decrease of psychological distress following one year of abstinence is 
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compelling. Most therapeutic interventions for SUD, including, cognitive behavioral therapy, 
motivational interviewing, and 12-step programs, are orally based treatment requiring 
widespread cognitive processing to facilitate cognitive, motivational, and behavioral change 
(Roehrich & Goldman, 1993). For instance, a common characteristic of most treatment 
initiatives includes learning the detrimental effects of several drugs, as well as the teaching of 
program rules and principal treatment philosophy (Grohman & Fals-Stewart, 2003), thus 
constituting a distinct learning prerequisite at the start of therapy. Our findings suggest that a 
gradual and careful step-up of learning requirements should be adopted, and emphasize that 
SUD treatment should primarily focus on stabilizing the patient and reaching abstinence, while 
interventions for co-morbid problems and more cognitively challenging treatment components 
be more likely to succeed later in the treatment sequence, as cognitive functioning improves.  
Moreover, these results raise the possibility that interventions specifically designed to improve 
cognitive function, such as memory training (Bickel, Yi, Landes, Hill, & Baxter, 2011), might 
facilitate somewhat more rapid recovery of cognitive function in this population. 
5.3.1 Conclusion 
To date, few studies have investigated the natural progression of recovery regarding this 
combination of outcome indicators in patients with PSUD. Our study provides support for the 
view that there is a clinically significant recovery in satisfaction with life, executive functions 
and psychological distress for patients with PSUD following one-year of abstinence. This 
improvement from admission to one-year, suggests that a gradual progression of treatment 
should be adopted to ensure that the patients have the prerequisites for receiving treatment in 
a broad array of dimensions. By this, our findings could shed light on the recovery process for 
this group of patients. It highlights the necessity of an ongoing diagnostic approach as the 
clinical picture at the admission of treatment could be dramatically improved for patients 
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suffering from PSUD. This knowledge could provide hope for patients, as well as a therapist, 
simply by highlighting the importance of time and continued abstinence. This might 
subsequently reduce dropout numbers and improve the recovery process for these patients. 
Future research should consider the timing and sequence of interventions in SUD treatment. 
5.4 Paper III 
SUD complicates the diagnostic procedures for patients with comorbid ADHD 
symptoms of hyperactivity, impulsivity, and inattention. These symptoms are, however, not 
limited to individuals with an ADHD diagnosis. Patients with SUD can develop impulsivity 
and hyperactivity, and have difficulty with attention as a result of the neurotoxic effects of the 
drugs that they use and the lifestyle associated with SUD (Yuan et al., 2009). Impulsivity and 
executive dysfunctions have been associated with almost all phases of SUD (Stevens et al., 
2014), as individuals with these characteristics have an increased probability of starting to use 
drugs, more destructive intensification of use, and more relapses after treatment (Jentsch, 
2009; Robbins, Gillan, Smith, de Wit, & Ersche, 2012; Winstanley, Olausson, Taylor, & 
Jentsch, 2010). 
Systematic use of screening tools to identify ADHD in childhood is infrequent, which 
creates a risk of leaving cases undetected  (Wilens et al., 2011). If these individuals later 
develop SUD, their attentional and impulsivity problems may be addressed for the first time 
as part of their SUD treatment. Our findings suggest that active SUD and the associated 
lifestyle could account for some of the problems related to sustained attention, concentration, 
and restlessness, as these ADHD symptoms were substantially reduced in our clinical sample 
after one year of abstinence. The clinical importance of this result is strengthened by previous 
studies with the same cohort that have demonstrated improved executive functions, increased 
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satisfaction with life, and reduced psychological distress (E Hagen et al., 2017). Thus, our 
findings support the recommendation from previous research that there should be a “treatment 
hierarchy” that begins with a treatment of the most prominent SUD symptoms and stabilization 
of the drug addiction (Wilens, 2004). 
The reduction in ADHD symptoms in the two PSUD groups in this study was compelling. 
The abstinence group showed a more profound reduction in severe ADHD symptoms, but the 
relapse group also showed some improvements. It is possible that, on average, SUD treatment 
improves ADHD symptomatology because it introduces a phase of stability and reduced 
substance use. Several inerventions are recommended for SUD, including motivational 
interviewing, cognitive-behavioral therapy, contingency management, and social skills 
training (Horsfall, Cleary, Hunt, & Walter, 2009).  These treatments all require cognitive 
processing (Roehrich & Goldman, 1993). This could include learning about program rules, 
treatment viewpoint, and the adverse consequences of various drugs (Grohman & Fals-
Stewart, 2003),  all of which represent a considerable learning prerequisite at the start of 
therapy. However, the present results suggest that a careful and stepwise approach to learning 
requirements should be adopted in treatment. This could be achieved through focus on 
stabilizing the patient, providing structure, and supporting abstinence from substance use. 
Diagnosing ADHD with active SUD is challenging. The risk of false-positive ADHD 
diagnoses in patients assessed by ASRS has been reported (Lugoboni et al., 2017; Roncero et 
al., 2015). Thus, our finding is a reminder that a period of abstinence, preferably evident by 
urine tests or other means of substance monitoring, should be in place before providing 





To our knowledge, this is the first study to report improvement of ADHD symptoms for people 
with PSUD during a 12-month treatment sequence. Our data suggest that there is a clinically 
(as well as a statistically) significant reduction in self-reported ADHD symptoms for SUD 
patients following one year of abstinence. This is useful knowledge for patients suffering from 
comorbid SUD and ADHD, as well as for clinicians. Our finding is a reminder that the 
assessment of ADHD should follow a period of abstinence to avoid false-positive ADHD 
diagnoses. Instead of focusing on ADHD as a persistent disorder, treatment should focus on 
how to support stable abstinence and how this may reduce ADHD-like symptoms.  
5.5 Strengths and limitations 
The study applied broad inclusion criteria, and patients were not excluded due to polydrug 
use, comorbid conditions or dropout from treatment. Hence it is likely that the participants 
reflect some of the heterogeneity characterizing clinical SUD populations.  Considerable 
efforts and resources were applied to ensure that we managed to keep attrition low (Svendsen 
et al., 2017), and we applied a dynamic assessment procedure that allowed for flexible 
assessment adjusted to the individual characteristics of the participants. We also applied a 
control group and also included a follow-up procedure for the control group. Practical 
implications of our findings in the PhD project have been and will continue to be presented to 
all the participating institutions in the project. We have so far held 4 town-hall meetings at 
“Folkets hus” in Stavanger where results and implications for treatment have been presented.  
Participants were recruited from different treatment facilities within the Stavanger 
University Hospital region. The patients were asked by their counselor whether they wished 
to participate. We have no data describing the patients that declined to participate. However, 
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a Norwegian study found a threefold increase in the rate of disability pensions among patients 
who chose not to participate in the Hordaland Health Study (Knudsen, Hotopf, Skogen, 
Øverland, & Mykletun, 2010). Furthermore, nonparticipants were characterized by poorer 
lifestyle habits including smoking, drug, and alcohol abuse (Korkeila et al., 2001; Shahar, 
Folsom, Jackson, & The Atherosclerosis Risk in Communities Study, 1996) and had lower 
scores on indicators of somatic and mental health (Drivsholm et al., 2006). It is, therefore, 
possible that the patients that declined research participation would have increased, rather than 
decreased, the group differences reported here. 
The SUD and control groups were different on several demographic variables. Age, sex, 
education, and IQ were included as covariates in the statistical analyses to adjust for this 
limitation somewhat. The significant difference in education between the SUD and control 
group was challenging to avoid. It was almost impossible to find control participants with 
fewer than ten years of education that did not have a substance-abuse problem. There was no 
significant age difference between patients and controls, which was a strength of the study as 
age is known to significantly impact neurocognitive functions. 
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6. Concluding remark and clinical implications 
Clinicians routinely focus on connecting with and treating patients based on their current 
psychiatric and emotional state and base their diagnosis and treatment efforts on those 
evaluations. However, neuropsychological assessment services are rare, expensive, and often 
involve a long waiting list for a thorough assessment. In paper I, we examined the use of a 
questionnaire-based inventory and several other performance-based measures of executive 
functions to assess their sensitivity to discriminate between patients with SUD and controls 
and to assess how these measures are associated with indicators of social adjustment. Our data 
indicate a promising potential for inventory-based EF assessment in SUD patients as measured 
by BRIEF-A. Self-report measures of EF can be valuable, cost-effective, and precise at an 
initial clinical evaluation, providing central complementary measures to performance-based 
tests.  Application of questionnaire-based inventories like Brief- A in the clinical units may 
also contribute to more focus on neurocognitive issues as well as providing a better basis for 
ward personell in communicating with the specialized neuropsychological treatment services. 
Paper II and III provide an argument for adopting a longitudinal diagnostic approach, as the 
diagnostic picture at the initial stage of treatment could be significantly altered if the patients 
manage to stay sober for one year. Premature diagnostic conclusions could inflict false-
positive diagnoses on patients regarding psychological status, EF, life dissatisfaction, and 
ADHD symptomatology. Finally, our findings particularly in paper II and III support and 
substantiate my initial curiosity mentioned in the preface, where I frequently observed a 
dramatic improvement among patients I had previously diagnosed and who managed to 




7. Future research 
Future research could focus on long-term cognitive restitution, beyond the scope of one-
year, focusing on the associations between changes in neurocognitive and psychological 
functioning and its effect on a broad array of outcome indicators, such as treatment efficacy, 
quality of life, mortality and occupational status.  
This could be done by combining cohorts like the Stayer cohort with other relevant 
national cohorts and compare these data with a selection of Norwegian national registries. 
Notification to the national registries is compulsory and the problem of loss to follow up is 
therefore negligible, and information bias is avoided. Linkage to registries is possible to repeat, 
and the clinical cohort may, therefore, be followed over several years without any 
inconvenience for the patient. Linkage of clinical data (testing and questionnaire data) and 
registry data could result in an enriched dataset with a wide variety of information that 
complete each other. This long-term perspective with numerous output indicators could prove 
vital in detailing the recovery process for this group of highly vulnerable patients. This could 
contribute to a better scientific and clinical understanding of the dynamic relationship between 
cognitive restitution, behavioral aspects of SUD, and treatment response, and could prove vital 
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Introduction: Chronic polysubstance abuse (SUD) is associated with neurophysiological and neuroanatomical
changes. Neurocognitive impairment tends to affect quality of life, occupational functioning, and the ability to
benefit from therapy. Neurocognitive assessment is thus of importance, but costly and not widely available.
Therefore, in a busy clinical setting, procedures that include readily available measures targeting core cognitive
deficits would be beneficial. This paper investigates the utility of psychometric tests and a questionnaire-based
inventory to assess “hot” and “cold” neurocognitive measures of executive functions (EF) in adults with a sub-
stance use disorder. Hot decision-making processes are associated with emotional, affective, and visceral re-
sponses, while cold executive functions are associated with rational decision-making.
Material and Methods: Subjects with polysubstance abuse (n = 126) and healthy controls (n = 32) were com-
pared on hot (Iowa Gambling Task) and cold (Stroop and the Trail Making Test) measures of EF, in addition to
a questionnaire assessing everyday EF related problems (BRIEF-A; Behavior Rating Inventory of Executive Func-
tion – Adult, self-report version). Information about the substance abuse and social adjustmentwere assessed by
self-report. Logistic regression analyses were applied to assess independent correlates of SUD status and social
adjustment. A multiple linear regression was performed to predict the number of previous treatment attempts.
Results: The psychometric test of hot EF (the Iowa Gambling Task) did not differentiate the patients with
polysubstance abuse from controls, and was not associated with social adjustment. The psychometric tests of
cold EF distinguished somewhat between the groups and were associated with one indicator of social adjust-
ment. The BRIEF-A differentiated between groups on all the clinical scales and was associated with three out of
five social adjustment indicators (“criminal lifestyle,” “conflict with caregiver,” and “stable housing.”).
Conclusions: The BRIEF-A inventory was the most sensitive measure of executive function in patients with sub-
stance use disorder, followed by measures of cold executive function. BRIEF-A should therefore be considered
as an integral part of the clinical routine when assessing patients with SUD.
© 2016 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/4.0/).
1. Introduction
Chronic substance use disorder (SUD) is associatedwith cognitive im-
pairment (Rogers & Robbins, 2001; Vik, Cellucci, Jarchow, & Hedt, 2004;
Yucel, Lubman, Solowij, & Brewer, 2007),with prevalence estimates vary-
ing between 20% and 80% among treatment-seeking abusers of alcohol
and drugs (Bates, Bowden, & Barry, 2002; Copersino et al., 2009).
Although the majority of studies have focused on disorders related
to alcohol use, there is growing evidence indicating similar cognitive
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deficits associated with polysubstance use (Fernandez-Serrano, Perez-
Garcia, & Verdejo-Garcia, 2011; Grant & Judd, 1976; Vik et al., 2004).
More specifically, abusers of alcohol, opiates, and stimulants show im-
pairment on tasks assessing different aspects of executive function
(EF), including decision-making and emotional control (Barry & Petry,
2008; Bechara, 2005; Dolan, Bechara, & Nathan, 2008; Verdejo-Garcia
& Bechara, 2010; Verdejo-Garcia, Bechara, Recknor, & Perez-Garcia,
2006). Central symptoms of EF deficits include reduced sensitivity to fu-
ture consequences and impaired decision-making in real-life situations
(Bechara et al., 2001;Grant, Contoreggi, & London, 2000; Schoenbaum&
Shaham, 2008), reduced ability to suppress responses and evaluate con-
sequences, as well as a preference for smaller, instantaneous rewards
over larger, delayed rewards (Cardinal, Winstanley, Robbins, & Everitt,
2004). These deficits commonly present even after 6 months of absti-
nence among polysubstance abusers (Fernandez-Serrano et al., 2011).
EF dysfunction has an impact on quality of life and occupational
functioning, which subsequently affects the course of rehabilitation
therapy and level of community integration among patients with SUD
(Fernandez-Serrano et al., 2011). In a clinical context, patients with
polysubstance abusemay demonstrate intelligence, learning andmem-
ory, language, and attentionwithin the normal range, butmay still show
considerable impairment in emotional function, decision-making, and
social behavior (Bechara, 2005). More specifically, an association has
been reported between cognitive deficits and low treatment adherence
(Bates, Pawlak, Tonigan, & Buckman, 2006), poor attendance at outpa-
tient therapy sessions (Guthrie & Elliott, 1980), low willingness to
change (Blume & Marlatt, 2009), reduced self-insight (Horner, Harvey,
& Denier, 1999), denial of substance abuse (Rinn, Desai, Rosenblatt, &
Gastfriend, 2002), increased impulsivity, and less abstinence from the
substance of abuse following treatment termination (Aharonovich
et al., 2006). Impaired EF has also been linked tomedical and legal prob-
lems among this patient group (Bechara et al., 2001; Paulus, Tapert, &
Schuckit, 2005).
With neurocognitive deficits recognized as an adverse variable af-
fecting recovery and treatment adherence in SUD patients, a thorough
examination of cognitive functioning, including assessment of EF, is of
paramount importance with regard to formulation of an effective and
clear individual treatment plan, and by this to facilitate improved every-
day coping and functioning in this patient population.
However, neurocognitive assessment services are both expensive
and time consuming. Furthermore, specialized neuropsychological ex-
pertise is usually rare in outpatient settings of SUD treatment. The infre-
quent inclusion of cognitive assessment in clinical practice was
illustrated in a recent study from Norway (Vaskinn & Egeland, 2012),
in spite of being recognized as important in the Norwegian national
guidelines for diagnosing and treating patients with SUD.
To sum up, it is important to develop and apply assessment proto-
cols that both are brief and simple enough to be included in a busy clin-
ical setting, and of importance to real-life situations and treatment.
The need for clinic-friendly neurocognitive measures motivated the
present study to investigate two theoretical EF components, referred to
as “cold” and “hot” EF, in a group of patientswith SUD. Both hot and cold
neurocognitive processes are involved in decision-making (Seguin &
Zelazo, 2005). Hot and cold decision-making processes are rarely inves-
tigated simultaneously. Often studies tend to emphasize the cold path-
way at the expense of the hot pathway (Séguin, Arseneault, & Tremblay,
2007). Previous studies have found, that when compared with controls,
SUD patients exhibit lower scores on performance based measures on
EF and emotion processing measures, and PET studies have established
an association between specific neural correlates related to cold and hot
executive functions, respectively (Moreno-López et al., 2012).
Related to decision-making, cold EF refers to abilities of importance
when contrasting various alternatives and comparing risk/benefit ratios
(Séguin et al., 2007). Cold cognitive processes are thus involved in a
wide range of abilities, including the ability to keep attention sustained
and focused, to be cognitively flexible, and be able to plan and organize
goal-directed behavior (Burgess, 2000; Stuss, Shallice, Alexander, &
Picton, 1995). These abilities are commonly measured by psychometric
tests such as the Stroop test (MacLeod, 1991) and the Trail Making Test
(Kortte, Horner, &Windham, 2002; Strauss, Allen, Jorgensen, & Cramer,
2005). Neurobiologically, these cognitive processes are shown to be
particularly associated with activation in dorsolateral prefrontal cortex
(Castellanos, Sonuga-Barke, Milham, & Tannock, 2006).
Hot EF involves processes with amore distinct emotional or motiva-
tional salience (Kerr & Zelazo, 2004; Zelazo & Müller, 2002), and have
increasingly been linked to the orbitofrontal cortex (Anderson, Barrash,
Bechara, & Tranel, 2006; Kerr & Zelazo, 2004). Impaired hot EF have a
strong impact on behavioral choices in everyday situations, especially
when stimuli with distinct emotional salience interact with logical or
cold EF (Sonuga-Barke, 2003). The conventional method for assessing
hot EF has been performance-based decision-making tasks with
emotional-laden contingencies (Chan, Shum, Toulopoulou, & Chen,
2008). A key challenge for participants in these tasks is to make long-
term advantageous decisions in uncertain and ambiguous test settings.
The Iowa Gambling Task (IGT) is one such test (Bechara & Damasio,
2002), where impairments has been shown in individuals with alcohol,
cocaine, and opioid use disorders (Bartzokis et al., 2000; Bechara &
Damasio, 2002; Bechara et al., 2001). It has even been argued that the
high proportion of relapse after treatment discharge may be attributed
to impaired hot EF, particularly when exposed to emotional-laden situ-
ations previously associated with substance abuse (Hunt, Barnett, &
Branch, 1971; McKay et al., 1997, 2004).
In addition to performance-based tests, EF can also be investigated
using self-report scales or questionnaires in which participants are
asked about their function in real-life situations. These scales, for exam-
ple the 75-item Behavior Rating Inventory of Executive Functions –
Adult Version (BRIEF-A) (Roth, Isquith, & Gioia, 2005; Roth, Lance,
Isquith, Fischer, & Giancola, 2013), have been shown to have a higher
ecological validity than results obtained in a structured test environ-
ment (Isquith, Roth, & Gioia, 2013; Roth et al., 2005). Furthermore,
they clearly have time and cost advantages over laboratory-based per-
formance measures.
With an aim to document EF impairment in patientswith SUDof im-
portance to real-life social adjustment and treatment, the present study
included a set of tests of the theoretical cold and hot components of EF,
including both psychometric tests and a questionnaire-based inventory
(BRIEF-A). We investigated their efficiency in characterizing the SUD
patients when compared to a control group.
2. Material and methods
2.1. Design
The study was part of a prospective, longitudinal cohort study of an
SUD patient sample who started a new treatment sequence in the Sta-
vanger University Hospital catchment area. This paper presents data
collected from SUD patients admitted to both outpatient and residential
treatment facilities. To minimize contamination from drug withdrawal
and acute neurotoxic effects from psychoactive substance, participants
were tested after 2 weeks of abstinence (Miller, 1985). The project
was approved by the Regional Ethical Committee (REK 2011/1877).
2.2. Participants and procedures
One hundred and fifty participants were recruited from outpatient
and residential treatment facilities within the region, across 10 enroll-
ment sites. Patients were recruited between March 2012 and May
2013. Consecutive enrollmentwas continued until the required number
of participants was recruited. The SUD group included patients
reporting use of more than one drug at a single occasion or a history
of having injected or abused multiple drugs, based on responses to the
Alcohol Use Disorders Identification Test (AUDIT) (Bohn, Babor, &
2 E. Hagen et al. / Journal of Substance Abuse Treatment 66 (2016) 1–8
Kranzler, 1995) and the Drug Use Disorders Identification Test (DUDIT)
(Voluse et al., 2012). Scores on these tests are summarized in Table 1.
Five patients were excluded due to not having a substance-related ad-
diction. One patient was excluded due to only using cannabis, one due
to only using opioids, and 14 due to only using alcohol. We did not ex-
clude patients with comorbid psychiatric conditions. The control
group (n=38)was a convenience sample recruited using posters at so-
cial welfare and primary care offices. Controls and patients were offered
compensation of NOK 400 for baseline testing. Nine patients (seven 17-
years of age, two 16-years of age) were excluded due to age. The final
group consisted of n = 126 SUD patients and n = 32 controls. Baseline
demographic variables for the control vs the SUD groups are summa-
rized in Table 2.
2.3. Inclusion procedure
Tobe eligible for admission to the study, patients needed to: a) sign a
written informed consent to participate; b) embark on a new treatment
sequence within the substance abuse treatment service; and c) be at
least 18 years of age. Patients also had to be enrolled in the program
to which they were admitted for at least 2 weeks, and abstinence was
verified through self-report, for both inpatients and outpatients. In
one of the first treatment sessions (1–3), patients were given an infor-
mation sheet with a short project description.
2.4. Measures
Cold EF is commonly measured with the computerized Stroop test
(Stroop CW) (Golden & Freshwater, 1978). Stroop is an assessment of
attention, interference, and inhibition of dominant responses
(MacLeod, 1991). Longer reaction times and number of errors indicate
impaired performance. Another measure of cold EF is the Trail Making
Test (TMT) (Kortte et al., 2002; Strauss et al., 2005). TMT provides
data on visual–conceptual and visual–motor tracking and set shifting.
There are two test subsections: Trail Making-A (TMT-A), in which the
targets are all numbers, and Trail Making-B (TMT-B), in which the sub-
ject alternates between numbers and letters. TMT-B is sensitive to cog-
nitive flexibility, sequencing, motor speed, and response inhibition.
Longer time to finish indicates impairment.
Hot EF has predominantly been examined using the Iowa Gambling
Task (IGT) (Bechara, Damasio, Damasio, & Anderson, 1994). The key
challenge in the IGT is to make advantageous long-term decisions in
conditions of uncertainty. For this test, subjects are given $2,000 to
start and their task is to maximize profit across 100 trials by choosing
cards from one of four decks. After 10 selections from decks A and B,
the subject will have earned a net loss of $250, whereas decks C and D
result in a net gain of $250. Consequently, decks A and B are the
“risky” decks. The hot element of IGT varies throughout the testing pro-
cedure. It is assumed that the perception of riskwithin the IGT increases
across trials, as subjects gain experiencewith thewin/loss contingencies
in the various decks (i.e. later trails have stronger emotional, or risky, as-
sociations) (Brand, Recknor, Grabenhorst, & Bechara, 2007).
The BRIEF-A is a self-report questionnaire composed of nine sub-
scales and three composite scores. The Behavioral Regulations Index
(BR-index) consists of the subscales inhibit, shift, self-monitor and
emotional-control. The subscales initiate, plan/organize, workingmem-
ory, organization of materials, and task-monitor comprise theMetacog-
nition Index (MI). The BRI and MI can be combined to produce the
overall global executive composite (GEC). Validity scales were exam-
ined, and two control and 10 SUD participants' profiles were excluded
due to invalid response styles.
Specific information on substance abuse was based on self-reported
responses on the AUDIT (Bohn et al., 1995) and theDUDIT (Voluse et al.,
2012). The Wechsler Abbreviated Scale of Intelligence (WASI) was in-
cluded as a control variable, because there was a significant difference
between controls and SUD patients on the univariate analysis, and to
ensure that EF deficits could not be attributed to general abilities.
After ensuring validity of WASIs' index levels, WASI full scale score
was used in further analysis. Experienced and trained psychometric
staff administered all tests. An interview based on items from the pre-
liminary version of the National Quality Register for Substance Abuse
Treatment was used to collect demographics, type of addiction, initial
age at use, treatment and work history, educational, and vocational
data. Social adjustment scores were obtained based on a yes/no re-
sponses from the same quality register, and included the following cat-
egories: permanent housing, criminal lifestyle, conflict with caregivers,
friends outside the drug environment, and stable income.
2.5. Statistical analyses
All statistical analyses were performed using IBM SPSS software (v.
22 for Windows). P-values b .05 were considered statistically signifi-
cant. Group differences were analyzed using Student's t-test, Mann–
Whitney tests, Pearson's χ2 test and Fisher's exact probability test (for
2 × 2 tables) as appropriate. Normality was controlled for using histo-
grams and Kolmogorov–Smirnov test, and Levene's test was used to se-
lect the appropriate p-values based onwhether the assumption of equal
variances within groups was met. Effect sizes are reported as Cohen's d
(standardizedmeandifferences), forwhich0.3 is considered a small, 0.5
a medium, and ≥0.8 a large effect (Cohen, 1992).
Binary logistic regression analyses (enter method) were applied to
assess independent correlates of SUD status and categorical variables in-
dicating social adjustment. In these analyses, control variables (age, sex,
years of education, andWASI Total IQ), and raw scores from the cold EF,
hot EF, and BRIEF-A BRI andMI, were sequentially entered to the analy-
ses. A multiple linear regression was performed to predict the number
of previous treatment attempts. As a quantified measure of goodness-
of-fit, Nagelkerke's R2 was estimated and reported. Due to the signifi-
cant difference in WASI total IQ between controls and patients, WASI
total IQ was included in a control variable in these analyses.
Table 1
Substance use and treatment history.
SUD patients (n = 126)
Age at initial use 13.1 (2.0)
Years of drug abuse 15.2 (8.0)
AUDIT total score 14.8 (10.5)
DUDIT total score 35.9 (8.5)








All data are mean (SD) unless otherwise indicated.
Table 2
Demographic variables for the control and SUD groups.
Controls (n = 32) SUD patients (n = 126) P-value
Male, n 13 (40.6) 85 (67.5) 0.005a
Age 33.7 (13.0) 28.5 (8.0) 0.064b
Years of education 14.5 (3.1) 11.7 (1.8) 0.001c
Native Norwegian, n 32 (100) 120 (95.2) 1.000d
Permanent home, n 32 (100) 71 (56.3) 0.001a
Stable income, n 29 (90.6) 87 (69.0) 0.014a
Criminal lifestyle, n 0 (0.0) 32 (25.4) 0.001a
Years of work experience 11.6 (9.4) 5.8 (5.9) 0.001b
WASI Total IQ 106.2 (13.2) 98.6 (11.6) 0.002c
a Pearson's χ2.
b Mann–Whitney U Test.
c Independent samples t-test.
d Fisher's exact test. All data are mean (SD), unless otherwise specified.
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3. Results
3.1. Demographics, substance abuse, and treatment history
A summary of the demographic variables is presented in Table 2.
There were significant differences in gender (40.6 % vs 67.5 % males in
control and SUD group) and years of education (14.5 ± 3.1 vs 11.7 ±
1.8) between the controls and SUD groups. Themean years ofwork expe-
rience was 11.6 (±9.4) in controls, compared to 5.8 (±5.9) in the SUD
group. There was also a moderate but significant group difference in
WASI Total IQ score in favor of the control group (d=0.611, p=0.002).
A summary of substance use and treatment history for SUD patients
is presented in Table 1. The mean debut age of drug use was 13.1
(±2.0), and the mean years of drug abuse was 15.2 (±8.0) years. The
mean AUDIT score was 14.8 (±10.5), and mean DUDIT score was 35.9
(±8.5). The majority (65.1 %) of the patients had tried injection as a
form of drug administration. For a detailed overview of the treatment
history of the patients, please refer to Table 1.
3.2. SUD vs control: executive functions
A summary of performance on cognitive tests for controls and SUD
patients is presented in Table 3. The control group significantly
outperformed the SUD group on the Stroop CWvariables word reading,
color naming and color/word naming, with moderate effect sizes. There
was no group difference on the Stroop Interference task. There was a
significant group difference on TMT part A (d = 0.452, p = 0.028) but
not TMT part B (d=0.086, p=0.658). The SUD groupwas slightly bet-
ter on IGT but this did not reach statistical significance for either the
total score or the learning curve IGT variables. Therewas a significant in-
crease in standard T-scores between SUD patients and controls on all
BRIEF-A subtests.
The results of all the regression analyses are summarized in Fig. 1.
Overall, SUD status was significantly associated with control variables
(χ2 = 53.53, p b 0.001; R2 = 0.336), and the BRIEF-A BRI and MI
(χ2 = 15.90, p b 0.001; R2 = 0.110). SUD status was not associated
with hot (χ2 = 1.49, p = 0.223; R2 = .010) or cold EF measures, al-
though the association is close to statistical significant for cold EF
(χ2 = 12.23, p = 0.057; R2 = 0.088).
3.3. Social adjustment
Overall, social adjustment variables were not linked to control vari-
ables; except that higher education was significantly related to “stabile
income” (B= 0.345, p=0.005) and “friends outside the drug environ-
ment” (B=0.464, p=0.008). Increased agewas also significantly relat-
ed to “stabile income” (B = 0.051, p = 0.048). Overall, there were no
significant associations between social adjustment and hot or cold cog-
nitive tests. However, increased T-scores on BRIEF-A BRI was signifi-
cantly related to adverse outcomes on “stabile income” (B = −0.77,
p = 0.007), “conflict with caregiver,” (B = 0.09, p =0.007), “stabile
housing” (B = −0.83, p = 0.002).
A multiple linear regression analysis (enter method) predicting the
number of previous treatment attempts was performed using the
same independent variables. The overall model was significant, and
more treatment attempts were predicted by increased score on Stroop
interference (B = 0.09, p N 0.001) and TMT part A (B = 0.04,
p N 0.038). The number of previous treatment attempts was also nega-
tively related to a reduced BRIEF MI score (B = −0.07, p = 0.014).
4. Discussion
Overall, the regression analyses in the present study found that the
BRIEF-A inventory was a significant predictor of substance use status.
The MI of BRIEF-A also predicted social adjustment scores, and the MI
predicted number of previous treatment sessions within the SUD
group. The contribution of the selected performance-based measures
was sparse, although group comparisons showed that the control-
group was faster on the three conditions from the Stroop test and the
Trail Making Test part A.
4.1. Group membership
The measures of cold EF distinguished between patients with SUD
and controls. The controlswere faster on the Stroop reading andnaming
tasks, and the Trail Making Test part A. These findings are in line with
previous research, where SUD patients often exhibit impairments in in-
hibitory control, set shifting and reduced ability to suppress responses
(Cardinal et al., 2004). This difference in cold EF is even evident in ado-
lescents at risk for developing SUDwhen compared to peers (McNamee
et al., 2008).
The SUD group performed slightly (but not significantly) better on
the hot EF, measured by the IGT total score. A similar paradoxical effect
on IGT performance and education has been documented in a previous
study, but existing studies vary in their findings. Functional impair-
ments based on IGT have been found in individuals with alcohol, co-
caine, and opioid use disorders, relative to healthy controls (Bartzokis
et al., 2000; Bechara & Damasio, 2002; Bechara et al., 2001). However,
findings are not conclusive, and a number of studies have shown that
groups of healthy controls do not learn to successfully select cards
from the advantageous decks, and also showing high variance in antic-
ipatory electro-dermal responses (Dunn, Dalgleish, & Lawrence, 2006).
The contradicting findings from some studies, where controls perform
poorly on IGT while not showing any deficiencies in real-life decision
making, makes it unclear whether IGT performance have predictive
value on real life functioning.
The demographic variables age, gender, education andWASI IQ pre-
dicted group membership better than the hot and cold EF measures.
WASI provides a brief assessment of general intellectual abilities
(Canivez, Konold, Collins, &Wilson, 2009), and these results are not sur-
prising, given the impact of the G factor; IQ scores correlate with aca-
demic performance and performance in other areas of life (Kline,
Table 3








Word reading 92.3 (13.9) 85.2 (12.8) 0.007 0.531
Color naming 69.0 (13.8) 62.3 (10.6) 0.013 0.545
Color/Word naming 43.8 (12.4) 38.9 (9.6) 0.019 0.441
Interference 4.3 (8.6) 5.9 (14.0) 0.524 0.137
Trail Making Test
Part A 26.1 (9.2) 31.8 (12.3) 0.016 0.524
Part B 62.9 (32.2) 73.1 (43.6) 0.157 0.267
Iowa Gambling Task
Total NET raw score 0.4 (18.6) 4.9 (26.0) 0.272 0.199
BRIEF-A§
Inhibit 51.1 (7.9) 64.4 (11.7) 0.001 1.332
Shift 50.9 (9.5) 62.2 (10.4) 0.001 1.134
Emotional control 40.3 (8.0) 59.0 (9.2) 0.001 2.169
Self-monitoring 50.6 (10.3) 59.8 (11.3) 0.001 0.857
BRI 50.3 (10.7) 63.4 (9.8) 0.001 1.276
Initiate 51.0 (10.7) 66.0 (11.2) 0.001 1.369
Working memory 53.7 (11.6) 65.2 (11.3) 0.001 1.004
Plan/Organize 53.2 (10.5) 63.0 (10.4) 0.001 0.937
Task monitoring 54.2 (10.6) 60.9 (11.2) 0.004 0.614
Organization of materials 50.1 (8.7) 55.2 (10.9) 0.019 0.517
Metacognition Index 52.8 (10.7) 64.0 (10.4) 0.001 1.061
BRI = Behavioral Regulation Index; All data are mean (SD), unless otherwise indicated.
The analysis on BRIEF-A shown above is therefore based on a sample of n = 30 control
and n = 116 SUD participants.
# Student's t-test.
⁎ Effect size reported as Cohen's d.
§ Due to invalid BRIEF-A protocols, n = 2 control and n = 10 SUD participants were
excluded from the analyses.
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2013b), and general intelligence can be understood as a broad reason-
ing ability that is useful in solving a wide variety of problems in life
(Kline, 2013a).
Responses on BRIEF-A was significantly elevated on all the nine scales
for SUD patients compared to the controls. Previous studies have found
similar results, where current polydrug users report significantly
more executive dysfunction on BRIEF-A, compared to non-users
(Hadjiefthyvoulou, Fisk, Montgomery, & Bridges, 2012). Several studies
have supported the validity of the BRIEF scales and other rating scales in
assessing every-day executive functioning (Isquith et al., 2013). Moreover,
there are established associations between BRIEF scores and correspond-
ing neural substrates (P. Anderson, 2002), ecological validity with regard
to predicting both every-day functioning (Isquith et al., 2013), and aca-
demic performance (Waber, Gerber, Turcios, Wagner, & Forbes, 2006).
Similar to our findings, it has proven difficult to establish associa-
tions between neuropsychological performance tests and rating scales
of EF, and this has raised questions whether the two assessment strate-
gies address different cognitive functions or different applications of
cognitive skills (Isquith et al., 2013; McAuley, Chen, Goos, Schachar, &
Crosbie, 2010). Isquith et al. (2013) offers a possible frame of explana-
tion where neuropsychological performance tests are hypothesized to
assess cold aspects of EF, and rating scales address a hot emotional as-
pect of EF. With regard to the BRIEF-A, this hypothesis draws support
from research that have applied confirmatory factor analysis of the
BRIEF-A scales, and detected a distinct emotional regulatory factor,
consisting of the Emotional Control and Shift scales (Gioia, Isquith,
Retzlaff, & Espy, 2002). Previous studies have speculated that the BR
index is in fact a measure of hot EF, in contrast to the less emotional
items constituting the remaining scales (Egeland & Fallmyr, 2010).
This distinct hot factor in BRIEF has been replicated in several studies
(McCandless & O' Laughlin, 2007; Peters, Algina, Smith, & Daunic,
2012). On the other hand, a recent study, (Skogli, Egeland, Andersen,
Hovik, & Øie, 2014) onhot and cold EF inADHD found no correlation be-
tween any of the BRIEF scales and performance based measures of hot
performance EF. The correlation matrix displayed marginally higher
correlation between cold EF tests and cold BRIEF scales than with the
hot BRIEF scales. Overall cold BRIEF scales reachedmoderate correlation
with cold EF tests. To our knowledge themajority of these findings have
been based on studies of with attention deficit hyperactivity disorder,
andwe have not succeeded in finding previous studies investigating as-
sociations between neuropsychological performance tests and rating
scales of EF adult SUD samples.
Fig. 1. Independent and dependent variables and results of the regression analyses. Level of prediction expressed as Nagelkerke's R2.
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4.2. Social adjustment
BRIEF-Awas associatedwith SUD aswell as some indicators of social
adjustment in SUD patients. Even when controlling for significant de-
mographic variables, the BRI in BRIEF-Awas associated with several do-
mains of social adjustment, where increased scores on the BRI of the
BRIEF-A were related to both substance abuse and lower social func-
tioning. The BRI consists of four subscales crucial for real-life adaptive
social behavior, which offers a plausible explanation for our findings.
The Inhibit scale assesses the ability to assert impulse control (go/no-
go), and towhat extent one is able to inhibit, stop or adjust one's behav-
ior when called for by the circumstances. The Shift scale assesses one's
ability to flexibly change from alternating situations, tasks or aspects
of challenges. The Emotional control scale assesses one's ability to regu-
late the expression of emotional responses, while the Self-Monitor scale
assesses interpersonal awareness and to which extent one understands
how one's behavior affects others (Roth et al., 2005). The BRIEF-A ques-
tionnaire measure participant's subjective evaluation about their func-
tion in real-life situations, and our findings suggest that the BRIEF-A
have a higher ecological validity than results obtained on performance
based tests.
We did not find any association between performance-based assess-
ment of hot or cold EF and SUD, or social adjustment in the SUD group.
There is a scarceness of literature detailing the link between perfor-
mance basedmeasures of hot and cold EF in SUD, and their relationwith
social adjustment. However, regarding neurocognitive predictors of so-
cial adjustment, studies of patients with closed brain injury indicates
that impairments in overall social adjustment (occupational status, lei-
sure activities, social contacts and family life), are closely linked to the
severity of the damage and subsequent cognitive sequela (Oddy,
Coughlan, Tyerman, & Jenkins, 1985).
Our findings suggest that typical and commonly used
neurocognitive performance based assessments might render a false
negative outcome in an initial evaluation, while a questionnaire-based
self-evaluation might predict impaired social adjustment associated
with substance abuse.
The lack of relationships between self-rating measures and perfor-
mance basedmeasures of EF could imply that they aremeasuring differ-
ent aspects of executive functions, and some suggest that performance
measures are particularly sensitive to components of executive func-
tions in isolation, while rating scales assess application of those skills,
(Isquith et al., 2013). It has been argued that traditional neuropsycho-
logical tests artificially fractionate an integrated functional network
(Burgess, 1997), and that the operationalization and types of methods
used to measure EF impacts the conclusions and interpretations we
can make. Our results indicate that IGT and BRIEF-A BRI assess two dif-
ferent cognitive constructs. IGT is presumably sensitive to subtle, un-
conscious perceptions of somatosensory feedback or “hunches” to
guide decision-making, whereas the BR index from BRIEF-A captures
the responder's own view of his or her ability to maintain appropriate
control of their own behavior and emotional responses (Roth et al.,
2005). This is supported by recent findings showing only minimal corre-
lations between the two types of measures (Toplak, West, & Stanovich,
2013), providing further support for the hypothesis that there are sepa-
rate EF pathwaysmeasured by IGT versus BRIEF-A (Sonuga-Barke, 2003).
4.3. Strengths and limitations
The SUDparticipantswere recruited from ten different treatment fa-
cilities within the Stavanger University Hospital region. The patients
were asked by their counselor whether they wished to participate. We
have no data describing the patients that declined research participa-
tion. A Norwegian study found a threefold increase in the rate of disabil-
ity pensions among patients who chose not to participate in the
Hordaland Health Study (Knudsen, Hotopf, Skogen, Øverland, &
Mykletun, 2010). Furthermore, nonparticipants were characterized by
poorer lifestyle habits including smoking and drug and alcohol abuse
(Korkeila et al., 2001; Shahar, Folsom, Jackson, & The Atherosclerosis
Risk in Communities Study, I, 1996) and had lower scores on indicators
of somatic andmental health (Drivsholm et al., 2006). It is therefore likely
that the patients that declined research participation would have in-
creased, rather than decreased, the group differences reported here.
The SUD and control groups were different on a number of demo-
graphic variables. Age, sex, education, and IQ were included as covari-
ates in the statistical analyses to adjust for this limitation somewhat.
The significant difference in education between the SUD and control
groupwas challenging to avoid. It was almost impossible to find control
participants with fewer than 10 years of education that did not have a
substance abuse problem.
This research field faces a number of interpretive challenges as to the
etiology of cognitive deficits associated with substance abuse. Psychiatric
comorbidity, medical risk factors (e.g. head trauma, HIV, malnutrition,
overdose), genetic predispositions, and premorbid vulnerability (e.g. ge-
netic, psychosocial, and environmental) may all play significant causal
roles leading to the current neuropsychological profile. Several psychiatric
diagnoses are characterized by changes in EF, and psychiatric functioning
was assessedwith self-report, and not supplementedwith observer-rated
scales. To ensure validity and reliability in assessment of psychopatholog-
ical symptoms, it is recommended that both subjective-, and observer rat-
ing are employed (Möller, 2009). Hence, it is possible that our findings
could be impacted by comorbid psychiatric symptoms.
Furthermore, although there is marked evidence of an association
between different aspects of SUD and cognitive impairment, the direct
versus indirect roles of the various substances are not clear. Theoretical-
ly, a number of cognitive deficits could be viewed as antecedents to the
onset of SUD, especially those involving EF connected to decision-
making and impulsivity (Nigg, Blaskey, Huang-Pollock, & Rappley,
2002; Nigg et al., 2006).
5. Conclusions
The BRIEF-A inventory was the most sensitive measure of EF in pa-
tients with substance use disorder, followed by measures of cold EF.
Evaluation with BRIEF-A should thus be considered as an integral part
of the clinical routine when dealing with assessment of patients with
SUD. Assessment of EFmay contribute to the scientific and clinical effort
of understanding the cognitive and behavioral aspects of SUD, and could
prove vital in tailoring SUD treatment programs, particularly consider-
ing the high dropout numbers at early treatment stages. However, it is
well known that neurocognitive assessment services are scarce, costly,
and generally unavailable to SUDpatients. Hence, it is crucial to develop,
evaluate, and apply testing procedures that could bemademore readily
available in busy clinical settings and that could also be administered by
a broader array of professions. Our data indicate a promising potential
for inventory-based EF assessment in SUD patients as measured by
BRIEF-A. Self-report measures of EF can be valuable, cost-effective, and
accurate at an initial clinical evaluation, providing important comple-
mentary measures to performance based tests.
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Introduction: Polysubstance use disorder is prevalent in treatment-seeking patients with substance use disorder
(SUD), with a higher risk of developing comorbid psychiatric symptoms, more pervasive deficits in cognitive
functions, and inferior treatment results. The present study investigates if individualswith polysubstance use dis-
order who achieve at least one year of abstinence show greater improvements in satisfaction with life, executive
functions, and psychological distress, compared to relapsers and controls. The prospective recovery from
polysubstance use disorder assessedwith broad output indicators remains understudied. A better understanding
of the pattern of recovery of the chosen output indicators could shed light on the recovery process for this group
of patients.
Material and methods: We investigated changes in satisfaction with life, executive functions and psychological
distress over a period of 12 months in patients who remained abstinent and in those who relapsed. Subjects
with polysubstance use disorder (N= 115) were recruited from outpatient and residential treatment facilities;
healthy controls (N = 34) were recruited by posters exhibited at social welfare and GP offices. Executive func-
tions were assessed by the Behaviour Rating Inventory of Executive Function-Adult self-report version (BRIEF-
A), psychological distress by the Symptom Checklist-90-R (SCL-90-R), and satisfaction with life by the Satisfac-
tionWith Life Scale (SWLS). Substance use was assessed by self-reports on the Alcohol Use Disorders Identifica-
tion Test (AUDIT) and the Drug Use Disorders Identification Test (DUDIT). Participants were categorized as
“relapsers” if they had AUDIT score ≥8, or DUDIT score ≥2 for women and ≥6 for men.
Results: Results indicated that the abstinent group had the greatest improvement on all the indicators compared
with relapsers and controls. Participants who successfully quit substance use for one year showed improved sat-
isfaction with life, executive functions, and psychological distress compared to participants who relapsed and
controls.
Conclusions:Our study provides support for the view that there is a clinically and statistically significant recovery
of satisfactionwith life, executive functions, and psychological distress for SUD patients following one-year of ab-
stinence. This knowledge highlights the importance of time and continued abstinence.
Our findings suggest that a gradual and careful step-up of learning requirement should be adopted, and SUD
treatment should initially focus on stabilizing the patient and achieving abstinence, while interventions for co-
morbid problems and more cognitively demanding treatment components are more likely to succeed later in
the treatment sequence.
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1. Introduction
Polysubstance use disorder is the most common diagnosis among
patients seeking treatment for substance use, and polysubstance use is
also associated with several challenges (Andrade, Carroll, & Petry,
2013). Comparedwith single-drug users, polydrug users have an earlier
onset of drug use and a higher rate of dropout (King & Canada, 2004;
Preti, Prunas, Ravera, & Madeddu, 2011), and they report higher levels
of general psychological distress (Andreas, Lauritzen, & Nordfjærn,
2015; Quek et al., 2013; White et al., 2013). This group reports more
symptoms of anxiety and depression (Booth et al., 2010; G. W. Smith,
Farrell, Bunting, Houston, & Shevlin, 2011), which is clinically relevant
because psychiatric comorbidity increases risk of relapse (Flynn &
Brown, 2008). Furthermore, polysubstance use disorder is associated
with pervasive deficits in cognitive functions, and significant impair-
ments have been reported on neuropsychological tests of working
memory, inhibition, cognitive flexibility, self-regulation, and decision-
making (Moreno-López et al., 2012). Cognitive impairments and psy-
chological distress thus place users with polysubstance use disorder at
preeminent risk of impaired recovery and more treatment dropout
(Preti et al., 2011) Consequently, treatment approaches for
polysubstance use disorder are less effective compared with treatments
for use of single substances (Connor, Gullo, White, & Kelly, 2014;
Williamson, Darke, Ross, & Teesson, 2006).
A number of studies have found a co-occurrence between mental
distress and dose- related polydrug use, and also a reduction of mental
distress among abstinent patients (Andreas et al., 2015). However, ef-
forts that focus on a broad spectrum of output indicators are needed
to shed light on the recovery process for this important and highly vul-
nerable subgroup of SUD patients. Polydrug users constitute a high risk
group comparedwith other SUD patients, withmore distinct depressive
and suicidal symptomatology at treatment admission (Riehman, Iguchi,
& Anglin, 2002), and also more social anxiety (Bakken, Landheim, &
Vaglum, 2005). Studies have shown that impaired psychiatric and cog-
nitive functions greatly diminish satisfaction with life (Burgess et al.,
2000). Satisfaction with life is also reduced among SUD patients, al-
though it has not been thoroughly investigated in patients with
polysubstance use disorder. (Donovan, Mattson, Cisler, Longabaugh, &
Zweben, 2005; K. Smith & Larson, 2003). As satisfaction with life is de-
scribed as a core motivator for and predictor of successful treatment, it
should be included as a key outcome indicatorwhen evaluating the suc-
cess of SUD treatment (De Maeyer, Vanderplasschen, & Broekaert,
2010).
Previous treatment studies of impaired executive functions in SUD
patients have several limitations. They have primarily dealt with the
acute and subacute effects of chronic alcohol and drug use
(Fernandez-Serrano, Perez-Garcia, & Verdejo-Garcia, 2011; Vik,
Cellucci, Jarchow, & Hedt, 2004; Yucel, Lubman, Solowij, & Brewer,
2007), and studies of long-term recovery do not always require a 14-
day drug-free period prior to baseline testing (Fernandez-Serrano et
al., 2011). Other studies have small sample sizes, oftenwith a focus onpa-
tients with one primary addiction (Badiani, Belin, Epstein, Calu, &
Shaham, 2011; Buelow & Suhr, 2009; Stavro, Pelletier, & Potvin, 2013).
In addition,many studies have used cross-sectional designs andare there-
fore unable to track changes in individual patients over time (van Holst &
Schilt, 2011). There is also considerable variability in the follow-up rates,
ranging from 40% to 98% (Cottler, Compton, Ben-Abdallah, Horne, &
Claverie, 1996; Desmond, Maddux, Johnson, & Confer, 1995; Stinchfield,
Niforopulos, & Feder, 1994), and some studies have not included a
follow-up procedure for a control group (Schulte et al., 2014).
We havenot been able tofindother studies that have focused on sat-
isfactionwith life, executive functions, and psychological distress during
the course of recovery for people with polysubstance use disorder, even
though a consideration of all these variables could prove important to
understand the course of recovery for these patients. The present
study features a prospective design and a control group, and was used
to address the following question: Will individuals with polysubstance
use disorder who achieve at least one year of abstinence show greater
improvements in satisfactionwith life, executive functions, and psycho-
logical distress, compared to relapsers and controls?
2. Material and methods
2.1. Participants
One hundred fifty SUD patients were recruited from 10 outpatient
and residential treatment facilitieswithin the Stavanger University Hos-
pital catchment area (Norway) betweenMarch 2012 andMay2013.We
employed broad inclusion criteria focusing on polysubstance use disor-
der because polysubstance use disorder is common in a clinical setting
(Badiani et al., 2011; Stavro et al., 2013). The main inclusion criteria at
baseline were: (a) evidence of SUD polysubstance use, operationalized
as the use of more than one drug on a single occasion, or a history of
abusing multiple drugs; (b) enrolled in a new treatment sequence by
the substance use treatment service; and (c) at least 16 years of age.
The control group (N= 38) was a convenience sample recruited by
posters exhibited at social welfare and GP offices. Controls and SUD pa-
tients were compensatedwith NOK 400 (~$US 50) for the baseline test-
ing. During the one-year follow-up period, 13 SUD patients and four in
the control group withdrew or dropped out of the study. The final
group included 115 SUD patients and 34 controls. This study was
reviewed and approved by the Regional Ethical Committee (REK
2011/1877) and conducted according to its guidelines and those of the
Helsinki Declaration (1975). Signed informed consent was obtained
from all the participants.
2.2. Procedures
The study is part of a prospective cohort study of a sample of SUD
patients in the Stavanger University Hospital catchment area. To mini-
mize contamination from drug withdrawal and acute neurotoxic effects
from psychoactive substances, baseline assessment was performed after
two weeks of abstinence (Miller, 1985) by experienced and trained
staff. Information on substance use was assessed using the Alcohol Use
Disorders Identification Test (AUDIT) (Bohn, Babor, & Kranzler, 1995)
and the Drug Use Disorders Identification Test (DUDIT) (Voluse et al.,
2012). At the one-year follow up, patients were defined as relapsing to
a significant level of use if they had an AUDIT score ≥8 or DUDIT score
≥2 for women and ≥6 for men (Bohn et al., 1995; Voluse et al., 2012).
2.3. Satisfaction with life
Satisfaction with life was assessed baseline and one year later with
the Satisfaction With Life Scale (SWLS) (Diener, Emmons, Larsen, &
Griffin, 1985). This is a self-report questionnaire including five items
measuring the global life satisfaction experienced by the respondent.
The SWLS has demonstrated good psychometric characteristics (Pavot
& Diener, 2008). The five items are all set in a positive direction, and
the total SWLS score (range = 5–35) was included in the present
study. A score of 20 represents a neutral point on the scale; scores be-
tween 5 and 9 indicate that the respondent is very dissatisfied with
life, while scores ranging between 31 and 35 indicate that the respon-
dent is very satisfied with life (Pavot & Diener, 2008). In this study
two patients did not complete the SWLS at the 1-year follow up, yield-
ing a response rate was 98.2% for patients and 100% for controls.
2.4. Executive functions
This study assessed executive functions by asking the participants to
complete the Behaviour Rating Inventory of Executive Function- Adult
version (BRIEF-A) (Gioia, Isquith, Guy, Kenworthy, & Baron, 2000;
Roth, Isquith, & Gioia, 2005) at baseline and one year later. The BRIEF-
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A has been shown to have high ecological validity (Gioia et al., 2000;
Roth et al., 2005), and to be associated with substance use status as
well as several social adjustment indicators in patients with a history
of polysubstance use disorder (Hagen et al., 2016). The BRIEF-A includes
three composite scores including sets of subscales. A Behavioural Regu-
lation Index (BRI-index) is calculated from the Inhibit, Shift, Self-Moni-
tor and Emotional Control subscales. The BRIEF-A Metacognition Index
(MI) is calculated from the Initiate, Plan/Organize, Working Memory,
Organization of Materials, and Task Monitor subscales. In this study
one patient and one control did not complete the BRIEF-A at the 1-
year follow up, yielding a response rate was 99.1% for patients and
97.1% for controls. Validity scales of the BRIEF-A were examined, using
the cut-off scores proposed by the original authors (Gioia et al., 2000).
Invalid response style led to exclusion of one control and nine SUD par-
ticipants at baseline, and three controls and five SUD participants at the
one-year follow up. The final sample included the 30 controls and 101
SUD patients with valid BRIEF-A protocols.
The Wechsler Abbreviated Scale of Intelligence (WASI) (Wechsler,
1999) was used to estimate intellectual function (IQ) by including two
tests of verbal crystallized abilities (Vocabulary and Similarities) and
two tests of nonverbal fluid-visual abilities (Block Design andMatrices)
(Canivez, Konold, Collins, & Wilson, 2009).
2.5. Psychological distress
Psychological distress was measured at baseline and one year later
using the Symptom Checklist-90-R (SCL-90-R) (Derrogatis, 1994). This
is a 90-item self-report symptom inventory that yields measures of nine
symptomdomains of psychological distress: (1) Somatization; (2) Obses-
sive compulsion; (3) Interpersonal sensitivity; (4) Depression; (5) Anxi-
ety; (6) Hostility; (7) Phobic anxiety; (8) Paranoid ideation, and (9)
Psychoticism. This study includes the nine subscales and the summary
score; Global Severity Index (GSI) (Derrogatis, 1994). In this study three
patients did not complete the SCL-90-R at the 1-year follow-up, yielding
a response rate was 97.4% for patients and 100% for controls.
2.6. Statistical analyses
Data were analyzed using IBM SPSS v22 for Mac. Statistical signifi-
cance was interpreted at p b 0.05 (two-tailed). Group differences were
analyzed using t-tests, Mann–Whitney U tests, and Pearson's chi
square-tests when appropriate. Levene's test was used to select the ap-
propriate p-values based onwhether the assumption of equal variances
within groups was met. Histograms, Q–Q plots, Kolmogorov–Smirnov
tests, and Shapiro–Wilk tests were used to investigate normality.
The research question was analyzed using mixed between–within
subjects' ANOVA to compare changes in abstainers, relapsers and con-
trols from the baseline to the one-year follow -up. Variables where the
three groups have similar patterns of change from baseline to one
year will not have a statistically significant interaction effect (the null
hypothesis). Variables where one group has a different pattern of change
from the other two groups are expected to show an interaction. To deter-
mine the cause of interaction effects, Wilcoxon signed rank tests were
used to evaluate median change from baseline to one year within each
group. Effect sizes were calculated as Cohen's r for nonparametric data,
where 0.3 is considered a medium and 0.5 is considered a large effect
(Cohen, 1988). Main effects were not interpreted in the presence of a
statistically significant interaction (Bordens & Abbott, 2002).
3. Results
3.1. Group characteristics
At baseline, patients and controls were similar according to age, but
controls were more often female (chi square = 5.8, p = 0.016), had
higher level of education (Z = 4.1, p b 0.001), and higher IQ score at
baseline (t = 3.2, p b 0.001). Clinical and demographic variables after
one year for patients who remained abstinent (N = 51), relapsers
(N = 64), and controls (N = 34) are summarized in Table 1. Although
there were no differences in baseline demographic variables between
the two SUD groups, the abstinent group obtained a higher score on
WASI IQ (t=2.2, p=0.030). Baseline levels of substance abuse, asmea-
sured bymean AUDIT/DUDIT score, did not differ between the two SUD
groups.
3.2. Satisfaction with Life Scale (SWLS)
Analysis of SWLS showed a significant main effect of group
[F(2144) = 59.8, p b 0.001] and time [F(1144) = 16.9, p b 0.001], and
a significant group × time interaction [F(2144) = 9.84, p b 0.001]. Fol-
low-up analyses showed that the interaction could be attributed to
the significant improvement in the abstinent group (Z = −4.86,
P b 0.001), with a medium to large effect size (r = 0.49). The relapse
and control group did not have statistically significant improvement.
See Fig. 1 and Table 2.
3.3. Executive functions in everyday life (BRIEF-A)
Analysis of the BRIEF-A Global Executive Composite (GEC) showed a
significant main effect of group [F(2125) = 20.4, p b 0.001] and time
Table 1
Baseline demographic and clinical variables for participants, grouped according to drug
use status after one year.




Age 28.7 (7.5) 27.1 (8.1) 30.9 (12.9)
Male gender, n (%) 35 (68.6%) 42 (65.6%) 15 (55.9%)
Years of education 11.9 (1.8) 11.6 (1.7) 14.2 (3.1)
AUDIT score at baseline 12.3 (9.8) 15.2 (10.5) 5.4 (3.8)
DUDIT score at baseline 36.6 (9.6) 35.3 (8.7) 0.3 (1.2)
WASI IQ 100.7 (11.5) 95.8 (12.1) 105.5 (13.6)
AUDIT=Alcohol Use Disorder Identification Test; DUDIT=Drug Use Disorder Identifica-
tion Test; WASI = Wechsler Abbreviated Scale of Intelligence. All data are means (SD),
unless otherwise indicated.
Fig. 1. Satisfaction with life “Satisfaction with life baseline and one year later measured
with the Satisfaction With Life Scale (SWLS). Mean value for the control group, the
participants that remained abstinent and the participants that relapsed to drug use.
Error bars: 95% Confidence interval.”
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[F(1125)= 17.5, p b 0.001], in addition to a significant group × time in-
teraction [F(2125)= 4.4, p=0.015]. The interaction is mainly attribut-
ed to the improvement in the abstinent group (Z = −4.52, P b 0.001),
with a medium to large effect size (r = 0.45), but some of the interac-
tion-effect could also be carried by an improvement in the control
group (Z=−2.04, P b 0.05), but this effect was small (r=0.2). The re-
lapse group did not show a statistically significant improvement. See
Fig. 2 and Table 2.
The BRIEF-A Behavioral Regulation Index (BRI) showed a significant
group × time interaction [F(2126) = 4.9, p = 0.009]. The interaction
could be attributed to the improvement in the abstinent group
(Z = −4.5, P b 0.001), with a large effect size (r = 0.6). Relapsers and
controls did not show a statistically significant improvement from base-
line to one year. BRIEF-AMetacognition Index (MI) showed a significant
group × time interaction [F(2126) = 4.0, p = 0.020]. The interaction
could be attributed to the improvement in the abstainers (Z = −4.5,
P b 0.001), with a large effect size (r = 0.6). Relapsers and controls
did not have statistically significant improvement. See Table 2.
3.4. Symptom Checklist-90-R (SCL-90-R)
Analysis of psychological distress as measured by SCL-90-R Global
Severity Index (GSI) showed a significant main effect of group
[F(2143)= 24.7, p b 0.001] and time [F(1143)= 23.8, p b 0.001], in ad-
dition to a significant group × time interaction [F(2143) = 11.0,
p b 0.001]. The interaction is mainly attributed to the improvement in
the abstinent group (Z=−4.50, P b 0.001), with a medium to large ef-
fect size (r=0.45), but some of the interaction-effect could also be car-
ried by an improvement in the relapse group (Z=−2.44, P b 0.05), but
this effect was small (r = 0.2). The control group did not have statisti-
cally significant improvement. See Fig. 3 and Table 2.
All nine SCL-90 subscales showed significant interactions at p b 0.05.
The abstinent group improved from baseline to one-year on all nine
subscales (p b 0.001). The relapse group improved on the subscales; Ob-
sessive compulsive, interpersonal sensitivity, depression, anxiety, pho-
bic anxiety and psychoticism at a p b 0.05 level, but showed no
significant change on the subscales somatization, hostility, paranoid
ideation. The control group had no change from baseline to one year
on any of the SCL-90 subscales. See Table 2.
3.5. 3.4 abstinent vs. controls at baseline and one year
At baseline the abstinent group had significantly worse SWLS score
(Z = −6.6, p b 0.001), BREIF-A GEC score (Z = −4.6, p b 0.001) and
SCL-90-R GSI score (Z = −5.0, p b 0.001) compared to the control
group. Comparing the scores at the 1-year follow-up between the absti-
nent and control group demonstrated a significant difference in scores
on SWLS score (Z = −3.91, P b 0.001) and BREIF-A GEC score
(Z=−2.21, P b 0.05), but no evident difference between these groups
on SCL-90-R GSI score. Although the abstinent group performed slightly
worse compared to the control group (see Fig. 3), this differencewas in-
significant and indicates a normalization of psychological distress fol-
lowing one year of abstinence.
3.6. Summary
Significant interactionswith group and timewere shown for all out-
come variables, with the abstainers showing the highest improvement
Table 2
Self-reported executive functioning, psychological distress and life quality during the 1 year follow up period.
Abstinent group (N = 51) Relapse group (N = 64) Control group (N = 32)
Baseline 1 year Z valuea Baseline 1 year Z valuea Baseline 1 year Z valuea
SWLS sum 15.7 (6.1) 21.1 (6.6) –4.9⁎⁎ 14.9 (5.8) 16.6 (6.1) –1.9 27.4 (4.8) 26.9 (5.5) –0.4
BRIEF-A GEC 64.8 (11.8) 55.0 (12.3) –4.5⁎⁎ 66.4 (9.4) 64.7 (10.2) –1.5 52.3 (10.4) 48.7 (12.7) –2.0⁎
BRIEF-A BRI 63.3 (11.2) 53.5 (11.5) –4.4⁎⁎ 64.0 (12.5) 63.3 (10.2) –0.2 51.0 (9.3) 49.3 (11.0) –1.9
BRIEF-A MI 64.0 (11.6) 55.3 (11.9) –4.5⁎⁎ 63.7 (13.1) 63.9 (11.0) –1.5 53.1 (10.7) 50.1 (10.3) –1.1
SCL-90-R GSI 1.0 (0.7) 0.5 (0.6) –4.5⁎⁎ 1.3 (0.6) 1.1 (0.6) –2.4⁎ 0.4 (0.4) 0.4 (0.5) –0.1
Somatization 0.87 (0.8) 0.43 (0.5) –3.8⁎⁎ 1.10 (0.7) 1.09 (0.8) –0.1 0.41 (0.5) 0.49 (0.5) –1.4
Obsessive compulsive 1.44 (0.8) 0.85 (0.8) –4.9⁎⁎ 1.61 (0.7) 1.43 (0.8) –2.1⁎ 0.58 (0.6) 0.52 (0.6) –1.0
Interpersonal sensitivity 1.22 (0.9) 0.59 (0.8) –4.5⁎⁎ 1.30 (0.7) 1.01 (0.7) –3.2⁎⁎ 0.38 (0.4) 0.41 (0.6) –0.6
Depression 1.23 (0.8) 0.66 (0.7) –4.5⁎⁎ 1.49 (0.7) 1.26 (0.8) –0.4⁎ 0.43 (0.5) 0.45 (0.5) –0.8
Anxiety 1.13 (0.9) 0.47 (0.6) –5.2⁎⁎ 1.42 (0.8) 1.26 (0.8) –2.1⁎ 0.32 (0.4) 0.35 (0.5) –0.7
Hostility 0.64 (0.8) 0.30 (0.5) –3.7⁎⁎ 0.91 (0.8) 0.81 (0.9) –1.2 0.20 (0.2) 0.23 (0.5) –0.8
Phobic anxiety 0.79 (0.9) 0.35 (0.6) –3.9⁎⁎ 1.10 (0.9) 0.84 (0.8) –2.1⁎ 0.17 (0.4) 0.19 (0.4) –0.2
Paranoid ideation 0.97 (0.9) 0.48 (0.7) –3.9⁎⁎ 1.21 (0.9) 1.10 (0.9) –1.2 0.35 (0.4) 0.35 (0.6) –0.7
Psychotisism 0.63 (0.7) 0.24 (0.4) –4.7⁎⁎ 0.71 (0.6) 0.52 (0.5) –2.55⁎ 0.14 (0.3) 0.24 (0.5) –1.8
All data are means (SD), unless otherwise indicated.
BRIEF-A GEC = Behaviour Rating Inventory of Executive Function–Adult Version Global Executive Composite; SCL-90-R GSI = Symptom Checklist-90-Revised Global Severity Index;
SWLS = Satisfaction With Life Scale; AG= Abstinent group; RG = Relapse group; CG= Control group.
⁎ P b 0.05.
⁎⁎ P b 0.001.
a Results of Wilcoxon signed rank test. This measures improvement in median score in this group from baseline until one year later.
Fig. 2. Executive functions “Executive functions at baseline and one year later measured
with the Global Executive Composite (GEC) from the Behavior Rating Inventory of
Executive Function – Adult Version (BRIEF-A). Mean value for the control group, the
participants that remained abstinent and the participants that relapsed to drug use.
Error bars: 95% Confidence interval.”
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on all variables (see Table 2). Overall, participants that successfully quit
substance use for one year show improved satisfaction with life, execu-
tive functions and psychological distress compared to participants that
relapse and controls.
4. Discussion
This study compared the change frombaseline to follow-up one year
later on self-reported satisfactionwith life, executive functions and psy-
chological distress. The participants were patients with polysubstance
use disorder who remained abstinent during the course of one year, pa-
tients who relapsed to substance use, and healthy controls. The absti-
nent group showed a significant improvement in perceived life
quality, executive functions, and psychological distress compared with
the relapsers and controls.
4.1. Improvement of satisfaction with life, executive functions and, psycho-
logical distress.
Executive functions (EF) improved in the group of abstinent patients
between baseline and one-year, but this was not the case with the pa-
tients that relapsed. Improvement of EF is very promising, considering
that maladaptive, impulse-driven behaviour is strongly associated
with a substance using lifestyle (Crews & Boettiger, 2009). Impulsivity
and impaired EF have been associated with almost all stages of the
SUD life cycle (Stevens et al., 2014): with increased probability of initi-
ating use, more aggressive escalation of use, failure to reduce consump-
tion and higher numbers of relapses after treatment (Jentsch, 2009;
Robbins, Gillan, Smith, de Wit, & Ersche, 2012; Winstanley, Olausson,
Taylor, & Jentsch, 2010). Notably, despite the improvement in EF in
the abstainers, they still had somewhat impaired function compared
with controls, which indicates that they still had some degree of vulner-
ability related to impaired EF, even after a year of abstinence.
Psychological distress decreased in the abstinent group. At the one-
year follow up, the disparity between the abstinent group and the con-
trols almost disappeared, suggesting a normalization of psychological
distress following one year of abstinence. Together with the differences
between the relapsers and abstinent patients on almost all SCL-90 sub-
scales, these results offer a promising view regarding initial recovery
from psychological distress in SUD patients. This finding is in line with
previous research that have found a reduction of psychological distress
among patients who stopped using multiple drugs (Andreas et al.,
2015), however it should be emphasized that the present study focused
on a broader spectrum of output indicators than previously reported.
There was a significant difference in perceived satisfaction with life
as measured by SWLS between the abstinent and relapse groups after
one year. The importance of this finding is substantiated by previous
studies showing an association between satisfactionwith life and subse-
quent symptoms in recovery, where satisfaction with life increases
through early recovery to stable abstinence (Laudet, Morgen, & White,
2006). Furthermore, a longer period of sobriety is shown to predict
higher levels of satisfaction with life one year later, and satisfaction
with life at the end of SUD treatment predicts commitment to sobriety
(Laudet et al., 2006).
Themultimodal improvement of satisfaction with life and executive
functionswith a decrease of psychological distress following one year of
abstinence is compelling. Most therapeutic interventions for SUD, in-
cluding, cognitive behavioral therapy, motivational interviewing, and
12-step programs, are verbally based interventions requiring extensive
cognitive processing to facilitate cognitive, motivational, and behavioral
change (Roehrich & Goldman, 1993). For instance, a common feature of
most treatment initiatives involves learning the harmful effects of vari-
ous drugs, as well as teaching of programme rules and overarching
treatment philosophy (Grohman & Fals-Stewart, 2003), thus
representing a distinct learning requirement at the onset of therapy.
Our findings suggest that a gradual and careful step-up of learning re-
quirements should be adopted, and emphasize that SUD treatment
should initially focus on stabilizing the patient and achieving absti-
nence, while interventions for co-morbid problems andmore cognitive-
ly demanding treatment components are more likely to succeed later in
the treatment sequence, as cognitive functioning improves. Moreover,
these results raise possibility that interventions specifically designed
to improve cognitive function, such as memory training (Bickel, Yi,
Landes, Hill, & Baxter, 2011), might facilitate somewhat more rapid re-
covery of cognitive function in this population.
4.2. Strengths and limitations
Many studies in this field have used cross-sectional designs (van
Holst & Schilt, 2011), and thus cannot track changes over time. We
have used a prospective design for the patient and control groups to en-
able control of training effects by repeated testing and reports on the
same questionnaires (Schulte et al., 2014). The mean IQ score of the
control group (104) was within the normal range for the population.
However, there was a significant difference in years of education, gen-
der distribution and work experience between the patient groups and
the controls (Table 1). These disparities are anticipated when compar-
ing a healthy control group and a clinical sample of patients with
polysubstance use disorder with a vast number of risk factors. With re-
gard to education, all Norwegian citizens have compulsory education
from five to 16 years old. It was difficult to recruit age-matched partici-
pants with fewer than 10 years of educationwho did not use drugs. The
skewed gender distribution, with the SUD group being 67% male and
the control group 55.9%male, may be explained by a factual gender dif-
ference in the prevalence of SUD between men and women; males are
more likely to suffer from lifetime and 12-month use and dependence
on drugs (Warner, Kessler, Hughes, Anthony, & Nelson, 1995). There
was no significant age difference between patients and controls,
which was a strength of the study as age is known to significantly im-
pact neurocognitive functions.
To ensure a diverse picture of the dimensions underlying recovery,
we broadened the scope of interest to satisfaction with life, executive
functions and psychological distress. By testing participants after
Fig. 3. Psychological distress “Psychological distress at baseline and one year later
measured with the Global Severity Index (GSI) from the Symptom Checklist 90 –
Revised (SCL-90-R). Mean value for the control group, the participants that remained
abstinent and the participants that relapsed to drug use. Error bars: 95% Confidence
interval.”
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14 days of detoxification, we aimed to exclude the possible subacute ef-
fects of the drug use (Fernandez-Serrano et al., 2011).
However, the present study has a number of limitations. First, it did
not incorporate a randomized design. Relapsers and abstainers self- se-
lected into their groups based on self-reports, and baseline or time-
varying variables that were not assessed may have influenced our out-
come variables. Thus, we cannot conclude that the differences in these
outcomes observed at 12 months were caused only by changes in sub-
stance use status. Furthermore, in this study we only addressed a fol-
low-up period of 12 months with only one follow- up wave, and the
control group was relatively small. It is possible that a larger control
group would have shown statistically significant improvements on EF.
It is however, unlikely that a large control groupwould change the over-
all impression that participants achieving one year of abstinence show
greater improvements compared to the other groups.
Finally, we were not able to determine the patterns of polydrug use
in our sample; that is, whether different substances were used concur-
rently, or before or after another drug. This information would be bene-
ficial to understand better the issues of polydrug use.
5. Conclusions
To date, few studies have investigated the natural progression of re-
covery in terms of this particular combination of outcome indicators in
patients with polysubstance use disorder. Our study provides support
for the view that there is a clinically significant recovery in satisfaction
with life, executive functions and psychological distress for
polysubstance using SUD patients following one-year of abstinence.
This improvement from admission to one-year, suggests that a gradual
progression of treatment should be adopted to ensure that the patients
have the prerequisites for receiving treatment in a broad array of di-
mensions. By this, our findings could shed light on the recovery process
for this group of patients. It highlights the necessity of an ongoing diag-
nostic approach as the clinical picture at the admission of treatment
could be dramatically improved for patients suffering for polysubstance
use disorder. This knowledge could provide hope for patients, as well as
therapist, simply by highlighting the importance of time and continued
abstinence. This might subsequently reduce dropout numbers and im-
prove the recovery process for these patients. Future research should
consider the timing and sequence of interventions in SUD treatment.
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A B S T R A C T
Introduction: Attention-deficit/hyperactivity disorder (ADHD) is a common comorbid disorder in patients suf-
fering from substance use disorder (SUD). Individuals with co-occurring SUD and ADHD are more likely than
SUD patients without ADHD to have developed SUD at a younger age, be polysubstance users, and need inpatient
treatment more often. The present study investigates whether individuals with polysubstance use disorder who
remain abstinent for a year after entering treatment have a more substantial reduction in ADHD symptoms than
those who relapsed and controls.
Material and methods: Subjects were SUD patients (N = 115) and healthy controls (N = 34). ADHD symptoms
were assessed using the adult ADHD Self-Report Scale (ASRS). Substance use was assessed by self-reports on the
Alcohol Use Disorders Identification Test (AUDIT) and the Drug Use Disorders Identification Test (DUDIT).
Participants were defined as having relapsed if they had an AUDIT score ≥ 8 or a DUDIT score ≥ 2 for women
and ≥ 6 for men.
Results: Patients who remained abstinent for one year reported a substantial reduction of ADHD symptoms
compared to patients who relapsed and controls.
Conclusions: Abstinence alleviates ADHD symptoms among patients with polysubstance use disorder. We suggest
that confirmation of an ADHD diagnosis should follow a period of abstinence to avoid identification of false-
positive cases.
1. Introduction
One of the most common disorders associated with substance use
disorder (SUD) is attention-deficit/hyperactivity disorder (ADHD)
(Brook, Whiteman, Cohen, Shapiro, & Balka, 1995; Kessler et al., 2006;
Wilens & Spencer, 2010). Nearly 25% of the adults between 18 and
44 years old who have been diagnosed with SUD in the United States
have also been diagnosed with ADHD (Kessler et al., 2006). Other
studies show that 40% of clinical SUD samples in different countries
screened positive for ADHD (Glind et al., 2013; van Emmerik-van
Oortmerssen et al., 2012).
ADHD has an adverse effect on the course of SUD (McAweeney,
Rogers, Huddleston, Moore, & Gentile, 2009; Wilens et al., 2011). Re-
lative to SUD patients without ADHD, SUD patients with ADHD are
more likely to have developed SUD at a younger age, become poly-
substance users, and need inpatient treatment more often (Arias et al.,
2008; Tamm et al., 2013). Also, SUD patients who screen for a con-
current adult ADHD diagnosis have been shown to have more severe
and chronic SUD (Young et al., 2015), and a childhood ADHD diagnosis
in SUD patients is associated with higher relapse rates after treatment
termination (Carroll & Rounsaville, 1993).
ADHD is manifested in childhood, and it persists into adolescence in
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almost 75% of the cases, and into adulthood in close to 50%
(Wilens & Spencer, 2010). Most studies have focused on how the onset
of ADHD, often in combination with conduct or bipolar disorders, in-
creases the risk of later SUD (Wilens et al., 2011).
Comorbid ADHD place patients with SUD at risk of impaired re-
covery, with longer duration of substance use and slower remission rate
(Wilens, Biederman, &Mick, 1998).
SUD complicates the diagnostic process, particularly for clients
identified with ADHD in adulthood and for those with symptoms below
the diagnostic threshold (Levin, Evans, & Kleber, 1998). Diagnosing
ADHD in adult patients with SUD requires accurate retrospective in-
formation, and this is often difficult to obtain because of inadequate
anamnestic data (Faraone et al., 2007; Levin et al., 1998). Conse-
quently, there is a group of adults who meet all the criteria for an ADHD
diagnosis except age at onset (Faraone et al., 2007). However, studies
have found that this group has similar forms of psychiatric comorbidity,
neurocognitive impairment, and familial transmission as the group with
a confirmed diagnosis, only differing on the childhood onset require-
ment of the Diagnostic and Statistical Manual of Mental Disorders-
Fourth Edition (DSM-IV) (Faraone et al., 2006; Faraone et al., 2006).
Furthermore, because SUD often emerges in adolescence, the apparent
late onset of ADHD may reflect the onset of SUD rather than ADHD, and
although subthreshold ADHD may be a milder form of the disorder
(Norén Selinus et al., 2016), it could also reflect nonspecific risk
characteristics for SUD rather than symptoms of ADHD (Faraone et al.,
2006). Taken together, this means that improvement of SUD symptoms
may also lead to an improvement of problems associated with ADHD
symptoms.
The present study investigates how 12 months of sobriety following
the onset of treatment affects the presence of self-reported ADHD
symptoms in a clinical sample of polysubstance users. Polysubstance
use disorder is frequent in clinical SUD samples (Andrade,
Carroll, & Petry, 2013). Comorbid ADHD place patients with SUD at risk
of impaired recovery, with longer duration of substance use and slower
remission rate (Wilens et al., 1998).
To our knowledge, this is the first study to report changes in self-
reported ADHD symptoms in people with polysubstance use disorder
during the 12-month period after initiation of treatment. Using a pro-
spective design and a control group, we addressed the following ques-
tion: Will individuals with polysubstance use disorder who remain ab-
stinent for one-year show a greater improvement in ADHD symptoms
compared with those who relapsed and controls?
2. Material and methods
2.1. Participants
One hundred and fifty SUD patients were recruited from 10 out-
patient and residential treatment facilities within the Stavanger
University Hospital catchment area (Norway) between March 2012 and
May 2013. We employed broad inclusion criteria focusing on poly-
substance use disorder because it is common in clinical settings
(Badiani, Belin, Epstein, Calu, & Shaham, 2011; Stavro,
Pelletier, & Potvin, 2013). The main inclusion criteria at baseline were:
(a) evidence of SUD with polysubstance use, operationalized as the use
of more than one drug on a single occasion, or a history of abusing
multiple drugs; (b) enrolled in a new treatment sequence by the sub-
stance use treatment service; and (c) at least 16 years of age. At base-
line, 22 patients were excluded because they did not meet the inclusion
criteria (four had no substance use addiction and 18 did not report
polysubstance use), leaving 128 patients in the study.
The control group (N = 38) was a convenience sample recruited by
posters exhibited at social welfare and GP offices. Controls and SUD
patients were compensated with NOK 400 (~USD 50) for the baseline
testing. During the one-year follow-up period, 13 SUD patients and four
people from the control group withdrew or dropped out of the study.
The final group included 115 SUD patients and 34 controls. The re-
tention rate was 89.8% for patients and 89.5% for controls. This study
was reviewed and approved by the Regional Ethical Committee (REK
2011/1877) and conducted according to its guidelines and those of the
Helsinki Declaration (1975). Written informed consent was obtained
from all participants.
2.2. Procedures
The study is part of a prospective cohort study of a sample of SUD
patients in the Stavanger University Hospital catchment area. To
minimize contamination from drug withdrawal and the acute neuro-
toxic effects of psychoactive substances, baseline assessment was per-
formed after two weeks of abstinence (Miller, 1985) by experienced and
trained staff. Information on substance use was assessed using the Al-
cohol Use Disorders Identification Test (AUDIT) (Bohn,
Babor, & Kranzler, 1995) and the Drug Use Disorders Identification Test
(DUDIT) (Voluse et al., 2012). At the one-year follow-up, patients were
defined as relapsing to a significant level of use if they had an AUDIT
score ≥ 8, or a DUDIT score ≥ 2 for women and≥ 6 for men (Bohn
et al., 1995; Voluse et al., 2012).
2.3. Adult ADHD self-report scale (ASRS)
The ASRS is a frequently used screening instrument for ADHD
(Kessler et al., 2005). It is composed of 18 items that reflect the
symptoms used to define ADHD according to the fifth edition of the
Diagnostic and statistical manual of mental disorders (DSMeV)
(Association, 2013). The results from this scale assess the presence of
ADHD symptoms, but on its own, it is not an adequate diagnostic tool.
Symptoms are rated on a 5-point Likert-type scale (0–4 = never,
rarely, sometimes, often, and very often), with a range of 0 to 72 for the
18-item instrument. This instrument has previously been validated in
SUD populations (Dakwar et al., 2012; Van de Glind et al., 2013).
In the present study, we included a sum score across all the 18 ASRS
items, a sum score for the ASRS items that assess inattention (items 1–4
and 7–11), and a sum score for the items that assess hyperactivity/
impulsivity (items 5, 6, and 12–18).
In order to highlight the severity of individual items in the ASRS, we
dichotomized responses to the ASRS items into “severe/not severe”
according to recommendations by Kessler et al. (Kessler et al., 2005).
Lastly, we used the “severe/not severe” dichotomized items to identify
clinically significant ASRS profiles. The ASRS profile was dichotomized
as “clinically significant” if ≥ 9 items were dichotomized as “severe”,
and "not clinically significant if< 9 items were dichotomized as se-
vere". This method is commonly used in clinical practice, and in line
with the original recommendations by Kessler et al. (Kessler et al.,
2005).
2.4. Statistical analyses
All analyses were performed using IBM SPSS v24 for Mac. Two-
tailed p-values< 0.05 were considered statistically significant. Data
were assessed for normality with histograms, Q–Q plots,
Kolmogorov–Smirnov tests, and Shapiro-Wilk tests. Visual inspection of
histograms and Q-Q-plots revealed that ASRS-scores at baseline and
1 year follow up did not deviate from normality. This was also evident
from the Kolmogorov-Smirnov test (D(149) = 0.05, p = 0.200; and
1 year D(149) = 0.06, p = 0.200, respectively) and Shapiro-Wilk test
(baseline w(149) = 0.99, p = 0.651; and 1 year w(149) = 0.99,
p = 0.327). Sub-analysis of normality for each participant group
yielded similar results (data not shown). As the data was normally
distributed, parametric statistics were used throughout. The statistical
procedures of the demographic variables have been published in a
previous paper (Hagen et al., 2017).
Mixed ANOVA was used to compare changes in abstainers,
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relapsers, and controls from baseline to the one-year follow-up.
Variables for which one group's responses differed from those of the
other two groups were expected to show a significant interaction. To
determine the cause of interaction effects, a paired samples t-test was
used to evaluate mean change from baseline to one-year within each
group. Effect sizes were calculated as Cohen's d for paired samples and
parametric data, where 0.5 was considered a medium effect and 0.8 was
considered a large effect (Cohen, 1988). Main effects were not inter-
preted in the presence of a statistically significant interaction
(Bordens & Abbott, 2002).
Lastly, the frequency of individual items dichotomized as severe was
estimated for each group (i.e., abstinent, relapsed, and control), and
changes in frequency during the one-year follow-up were investigated
for each item using a repeated measures ANOVA. As multiple com-
parisons were made, Bonferroni adjusted P-values (0.05/18 = 0.003)
were used to establish statistical significance.
3. Results
3.1. Group characteristics
We presented data for the clinical and demographic variables for
patients who remained abstinent for a year (N = 51), patients who
relapsed (N = 64), and controls (N = 34) in a previous paper (Hagen
et al., 2017). In short, patients and controls did not differ in age, but
controls were more often female (44% vs. 33%) and had a higher mean
level of education (14.2 vs. 11.8 years) and a higher mean IQ score
(105.5 vs. 98.2) at baseline. Three patients and five controls were<
18 years of age at the time of inclusion. Although there were no dif-
ferences in baseline demographic variables between the two SUD
groups, the abstinent group obtained a higher mean WASI IQ score
(100.7 vs. 95.8). As measured by the mean AUDIT/DUDIT score,
baseline levels of substance abuse did not differ between the two SUD
groups.
3.2. ASRS total score
At baseline, there was a significant difference (t = 6.4, p < 0.001)
in ASRS total score between patients (m = 34.7, SD = 10.7) and con-
trols (m = 21.2, SD = 11.4). At baseline, patients who relapsed during
the follow-up period had a higher ASRS total score than patients who
remained abstinent, but this difference was not statistically significant
(Table 1). Repeated measures ANOVA showed a significant effect of
group [F(2146) = 18.0, P < 0.001] and time [F(1146) = 25.7,
p < 0.001], and a significant group × time interaction [F(2146)
= 10.2, p < 0.001] (illustrated in Fig. 1). Follow-up analyses showed
that the interaction could be attributed to the significant alleviation of
ADHD symptoms in the abstinent group (t = 5.5, p < 0.001), with a
large effect size (d= 0.82), and significant symptom improvement in
the relapse group (t = 2.4, p = 0.017), with a moderate effect size
(d= 0.37). In the control group, the ASRS total score did not change
from baseline to one year later (m = 21.2, SD = 11.4 vs. m = 21.0,
SD = 9.4). At both time-points, the total score in the control group was
slightly lower than that at follow-up in the SUD patients who were
abstinent (m = 23.3, SD = 14.4), and considerably lower compared
with those who relapsed (m = 31.6, SD = 9.6).
3.3. Inattention symptoms
At baseline, there was a significant difference (t = 6.4, p < 0.001)
in inattention symptoms between patients (m = 18.6, SD = 6.4) and
controls (m = 10.6, SD = 6.1). The patient groups (abstained and re-
lapsed) did not differ at baseline on the ASRS inattention subscale.
Repeated measures ANOVA showed significant main effects of group [F
(2146) = 18.0, p < 0.001] and time [F(1146) = 21.1, P < 0.001],
and a significant group × time interaction [F(2146) = 10.2,
p < 0.001]. Follow-up analyses showed that the interaction could be
attributed to the significant improvement in the abstinent group
(t = 5.5, p < 0.001), with a medium to large effect size (d= 0.82),
and a significant improvement in the relapse group (t = 2.3,
p = 0.025), with a small effect size (d = 0.31). The ASRS inattention
score in the control group did not change over time.
3.4. Hyperactivity-impulsivity symptoms
At baseline, there was a significant mean difference (t = 6.4,
p < 0.001) between patients (m = 16.1, SD = 5.9) and controls
(m = 10.6, SD = 6.2) on the ASRS hyperactivity/impulsivity subscale.
The patient groups did not differ on this score at baseline, but the re-
peated measures ANOVA showed significant main effects for group [F
(2145) = 10.8, p < 0.001] and time [F(1145) = 17.9, p < 0.001],
and a significant group × time interaction [F(2145) = 5.4, p = 0.006].
Follow-up analyses showed that the interaction could be attributed to
significant improvement in the abstinent group (t = 4.5, p < 0.001),
with a moderate effect size (d = 0.66), and significant improvement in
Table 1

























































All data are means (SD).
a Results of paired samples t-test. This measures improvement in mean score from
baseline to one-year later within the group.
b Number with clinical score is indicated by [N].
⁎ p < 0.05.
⁎⁎⁎ p < 0.001.
Fig. 1. Mean ASRS sum score for each group at baseline and one-year follow up.
Footnote: Changes in mean ASRS sum score from baseline to one-year for each group.
Standard deviation indicated by error bars.
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the relapse group (t = 2.4, p = 0.021), with a small effect size
(d= 0.31). The change in the hyperactivity-impulsivity subscale was
not statistically significant for the control group.
3.5. ASRS scores indicating severe ADHD symptoms
The frequencies of number of severe ADHD symptoms (in total) for
each group are presented in Fig. 2. Overall, patients reported a sig-
nificantly higher number of severe symptoms than controls at baseline
(t = 6.1, p < 0.001). The frequency of severe symptoms did not differ
between the two patient groups at baseline (t = 0.6, p = 0.570). The
abstinent group demonstrated a significant decrease (t = 4.4,
p < 0.001) in severe symptoms from baseline (m = 7.3, SD = 4.3) to
1 year (m = 4.3, SD = 4.5), whereas the changes in the relapse group
(t = 2.0, p = 0.054) and the control group (t = −0.1, p = 0.937)
were not statistically significant.
The percentages of severe symptoms are presented for each group
on each ASRS item in Table 2. The control group had no statistically
significant change from baseline on any items of the ASRS. The relapse
group had significant change on two symptoms, but these did not
withstand Bonferroni correction for multiple comparisons. For the ab-
stinent group, eight items demonstrated a significant improvement
from baseline to the one-year follow-up, but only three items were
considered statistically significant following Bonferroni correction:
Item 8: sustained attention (F[1, 50] = 14.8, p < 0.001), Item 9:
concentration when listening (F[1, 50] = 24.3, p < 0.001), and Item
13: Restlessness (F[1, 50] < 27.3, p < 0.001).
4. Discussion
This study compared patients with polysubstance use disorder who
remained abstinent, patients who relapsed, and healthy controls on
changes in self-reported ADHD symptoms from baseline to follow-up
assessment one year later. The abstinent group showed a substantial
reduction of ADHD symptoms compared with the relapse and control
groups. In fact, the scores of the abstinent group at follow-up were only
slightly higher than those of the healthy controls, who were in the
normal range for ADHD symptoms at both baseline and follow-up. The
improvements in the abstinence group were particularly prominent on
the ASRS items that reflect problems related to sustained attention,
concentration, and restlessness.
4.1. Improvement of self-reported ADHD symptoms
SUD complicates diagnostic procedures and accuracy for patients
with comorbid ADHD symptoms of hyperactivity, impulsivity, and in-
attention. These symptoms are, however, not restricted to individuals
with an ADHD diagnosis. Patients with SUD can develop impulsivity
and hyperactivity, and have difficulty with attention as a result of the
neurotoxic effects of the drugs that they use and the lifestyle associated
with SUD (Yuan et al., 2009). Impulsivity and executive dysfunctions
have been associated with almost all stages of SUD (Stevens et al.,
2014), as individuals with these characteristics have an increased
probability of starting to use drugs, more destructive intensification of
use, and more relapses after treatment (Jentsch, 2009; Robbins, Gillan,
Smith, de Wit, & Ersche, 2012; Winstanley, Olausson, Taylor, & Jentsch,
2010).
Systematic use of screening tools to identify ADHD in childhood is
rare, which creates a risk of leaving cases undetected (Wilens et al.,
2011). If these individuals later develop SUD, their attentional and
impulsivity problems may be addressed for the first time as part of the
initial diagnostic work in the SUD. Our findings suggest that active SUD
and the associated lifestyle could account for some of the problems
related to sustained attention, concentration, and restlessness, as these
ADHD symptoms were substantially reduced in our clinical sample after
one year of abstinence. The clinical importance of this result is
strengthened by previous studies with the same cohort that have de-
monstrated improved executive functions, increased satisfaction with
life, and reduced psychological distress (Hagen et al., 2017). Thus, our
findings support the recommendation from previous research that there
should be a “treatment hierarchy” that begins with treatment of the
most prominent SUD symptoms and stabilization of the drug addiction
(Wilens, 2004).
The reduction in ADHD symptoms in the two polysubstance use
disorder groups in this study was compelling. The abstinence group
showed a more profound reduction in severe ADHD symptoms, but the
relapse group also showed some improvements. It is possible that, on
average, SUD treatment improves ADHD symptomatology because it
introduces a period of stability and reduces substance use. Several
psychosocial treatments are recommended for SUD and comorbid
mental disorders, including motivational interviewing, cognitive-be-
havioral therapy, contingency management, relapse prevention, case
management, and social skills training (Horsfall, Cleary,
Hunt, &Walter, 2009). To make behavioral changes, these treatments
for SUD require cognitive processing and learning abilities
(Roehrich & Goldman, 1993). This could involve learning about pro-
gram rules, treatment philosophy, and the negative effects of different
drugs (Grohman & Fals-Stewart, 2003), all of which represent a sub-
stantial learning requirement at the onset of therapy. However, the
present results suggest that a slow, careful, stepwise approach to
learning requirements should be adopted in treatment, one that initially
focuses on stabilizing the patient, providing structure, and supporting
abstinence from substance use.
Diagnosing ADHD with active SUD is challenging. The risk of false-
positive ADHD diagnoses in patients assessed by ASRS has been re-
ported (Lugoboni et al., 2017; Roncero et al., 2015). Thus, our finding is
a reminder that a period of abstinence, preferably evident by urine tests
or other means of substance monitoring, should be in place before
providing conclusions regarding an ADHD diagnosis.
4.2. Strengths and limitations
Many studies in this field have used cross-sectional designs (van
Holst & Schilt, 2011), and thus they were unable to track longitudinal
changes. We used a prospective design for the patient and control
groups, which allowed us to monitor possible training effects through
repeated testing and reports on the same questionnaires (Schulte et al.,
2014). However, there was a significant difference in years of
Fig. 2. Mean frequency of severe ADHD symptoms (in total) for each group.
Footnote: Changes in frequency of severe ADHD symptoms from baseline to one-year for
each group.
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education, gender, and work experience between the patients and
controls. Regarding education, all Norwegian citizens receive compul-
sory education from 5 to 16 years of age. Hence, it was difficult to re-
cruit age-matched participants with fewer than 10 years of education
who did not use drugs.
The present study has several other limitations. First, the patients in
the relapse and abstinence groups were self-selected (based on their
self-reports), and time-sensitive variables that we did not assess may
have influenced our outcome variables. Thus, we cannot conclude that
the differences in the outcomes observed at 12 months were only
caused by changes in substance use status. Furthermore, we only as-
sessed ADHD symptoms at baseline and one-year follow-up; therefore,
we cannot determine when the abstinence group's improvements in
ADHD symptoms occurred during the follow-up period. In addition, the
assessment of ADHD symptoms with ASRS does not constitute a full
diagnostic procedure. Without historical anamnestic data in our study,
it is difficult to suggest whether the alleviation of symptoms only ap-
plies to a subthreshold group of patients or if it is also associated with
late-onset ADHD diagnosis.
Future research should include longitudinal prospective cohort
studies with repeated measures of the trajectories of ADHD sympto-
matology in SUD patients. The presence or absence of ADHD should be
assessed at baseline or collected from hospital journal data whenever
possible. Cohort studies assessing ADHD in childhood, focusing on the
participants developing SUD later in the trajectory, could provide va-
luable information and possibly explain the mechanism behind the
findings presented here.
5. Conclusions
To our knowledge, this is the first study to report improvement of
ADHD symptoms for people with polysubstance use disorder during a
12-month treatment sequence. Our data suggest that there is a clinically
(as well as a statistically) significant reduction in self-reported ADHD
symptoms for SUD patients following one year of abstinence. This is
useful knowledge for patients suffering from comorbid SUD and ADHD,
as well as for clinicians. Our finding is a reminder that the assessment of
ADHD should follow a period of abstinence to avoid false-positive
ADHD diagnoses. Instead of focusing on ADHD as a persistent disorder,
treatment should focus on how supporting stable abstinence may re-
duce ADHD-like symptoms.
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